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ABSTRACT 
The mitogen-activated protein kinase 5 (MK5) binds to extracellular signal-regulated kinase 3 
and 4(ERK3 and ERK4) through a unique FRIEDE motif in ERK3/4. 100 amino acids C-
terminal in MK5 is sufficient for this binding. MK5s subcellular localization and activity is 
regulated by the atypical MAP kinase ERK3 and ERK4. In this project we wanted to express 
and purify full-length and different domains of MK5 and use it to gain structural information 
of the kinase to further reveal how it binds to ERK3 and ERK4 at the atomic level. Recombinant 
technics for generation of these proteins together with functional assays to assess the activity 
of MK5 have been used. Optimal protocols for expression and purification of the kinase was 
developed. Finally we used a GST pulldown assay to show that the amino acid domain amino 
acid domain 372-473 of MK5 are able to bind to ERK4 in extracts from mammalian cells.  
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ABBREVIATIONS 
AMP  Ampicillin 
CAM  Chloramphenicol 
dNTP  Deoxyribonucleoside triphosphates 
GST  Glutathione S-transferase 
IMAC  Immobilized metal Ion affinity chromatography 
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LB  Lysogeny Broth 
MAPK Mitogen-activated protein kinase 
Ni-NTA Nickel-nitrilotriacetic acid 
PBS  Phosphate Buffered Saline 
PCR  Polymerase Chain Reaction 
SDS-PAGE Sodium dodecyl sulfate - polyacrylamide gel electrophoresis 
STM  Streptomycin 
TB  Terrific broth 
TBS-T  Tris-buffered saline – tween 20 
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INTRODUCTION 
Cancer is among the leading causes of morbidity and mortality worldwide, with approximately 
14 million new cases and 8.2 million cancer related deaths in 20121. Norway with a population 
of more than 5 million people, 31 651 new cases were reported in Kreftregisteret according to 
Cancer in Norway 20142. Cancer is when abnormal cells divide uncontrollably. They can 
invade and spread to distant sites of the body. Metastasis is the spread of cancer cells to other 
organ site. Hallmarks of Cancer: The Next Generation describes the six hallmarks of cancer, 
which are typical for cancer cells3. These events are sustained proliferative signaling where 
cancer cells receive growth-promoting signals, evading growth suppressors, resisting cell death, 
enabling replicative immortality by exceeding senescence and apoptosis and therefore allowing 
multiple replication, inducing angiogenesis as blood supply to the cancer tumors, and activating 
invasion and metastasis. Better understanding of these characteristics will further develop new 
means to fight cancer3. 
There are more than 100 types of cancer, and types of cancer is usually named after where the 
cancer occurs in the bodily organs or tissues. For example, carcinoma arises in the epithelium, 
which is the tissue that covers the outside of the organs and body. Cancer is a genetic disease 
and three main types of genes contribute to the development of cancer. These are 1) proto-
oncogenes, which often encode proteins for function of cell division, and differentiation, and 
stop cell death. These proto-oncogenes can become tumour-causing genes, the oncogenes, 
allowing cells to grow uncontrollably and resist cell death. 2) tumor suppressor genes that 
express proteins for controlling cell growth, and 3) DNA repair genes that repair damaged DNA 
genes. Mutations in any of these genes may lead to cancer formation4,5. 
Currently cancer can be treated with surgery (removal of malignant tumor), radiation therapy, 
chemotherapy, immunotherapy, targeted therapy, hormone therapy and stem cell transplant. 
One can only have one type of treatment or combination of treatments6. Kinase inhibitors are a 
subclass of chemotherapy and has been an interesting field among researchers. 30 substances 
are now in clinical use and more than 130 are in phase 1-3 clinical trials7.  
Signal Transduction 
Signal transduction describes how cells receive, process, and respond to information from the 
environment8. Extracellular molecular signals transmit into a cell before it gives a response. 
How the transmission takes place, is determined by receptors, which are proteins that receive 
molecular signals outside the cells. Signaling transducing receptors are of four classes; 1) 
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Enzyme-linked receptors, which penetrate the cell membrane and have intrinsic enzymatic 
activity or association with intracellular enzyme, 2) G protein-coupled receptors, which are 
coupled to G proteins inside the cell, 3) nuclear receptors, which are within the cell and alter 
gene expression and 4) Ligand-gated ion channels that allow passage of ions upon activation.  
Upon activation of the receptor, an event of signaling cascade takes place where enzymes act 
on one another in a specific way. This gives a physiological response that is specific and 
appropriate. The small molecules, which participate in intracellular signaling, are called second 
messengers. These include cAMP, cGMP, nitric oxide, lipids and Ca2+ ions. Once the receptor 
is activated, it stimulates the second messenger production, which then activate other enzymes 
within the cascades10. This does not apply for enzyme-linked and nuclear receptors however. 
Enzyme-linked receptors initiate signaling cascades and hence the intrinsic enzyme activity 
through multi-subunit transmembrane proteins9. Nuclear receptors are a large family of 
transcription factors that bind to DNA and start transcription and translation of target DNA 
sequence11. 
Kinases 
Kinases are enzymes that phosphorylate other molecules, adding a phosphate group (PO4
3-). 
This phosphate group is from adenosine trisphosphate (ATP). Kinases are involved in many 
cellular processes. They are further named after what the target molecule is. For example, 
kinases that phosphorylate proteins are called protein kinases and kinases that phosphorylate 
lipids are called lipid kinases12,13. 
Protein kinases attach the phosphate group onto a protein (Figure 1). From there they regulate 
signal transduction and cellular processes. These include metabolism, transcription, cell cycle 
progression, cytoskeletal rearrangement and cell movement, apoptosis, and differentiation. In 
addition, protein kinases are important in intercellular communication during development, in 
physiological responses and in homeostasis, and in functioning of the nervous and immune 
systems. Protein kinases phosphorylate serine/threonine (Ser/Thr) or tyrosine(Tyr) on the side 
chains in proteins14,15. There are 518 annotated protein kinases in human, where 478 belong to 
a single superfamily whose catalytic domains are related in amino acids sequence, which 
consists of 250-300 amino acids13,14. These domains are called eukaryotic protein kinase (ePK) 
catalytic domain. The remaining 40 protein kinases are what is called atypical protein kinase 
(aPK)14,15. ePKs are further divided in seven major groups (Figure 2) according to their 
similarity and biochemical functions16. 
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Figure 1 Phosphorylation. The kinase is a protein kinase that adds a phosphate group P from an adenosine triphosphate (ATP) 
to a protein. ATP becomes adenosine diphosphate (ADP) dues to the loss of a phosphate group. Shape-shifting of the protein 
occurs due to conformational change. 
 
 
Figure 2 The Human Kinome. The Eukaryotic protein kinases are divided in seven major groups. The ERK3/ERK4 signaling 
pathway is in the CMGC group (derived from 15). 
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Enzyme Inhibition 
The activity of an enzyme can be reduced or inhibited by specific molecules. Molecules that 
inhibit an enzyme are called inhibitors. They play a major role in the regulation mechanism in 
biological systems. The inhibition is divided into reversible and irreversible. Irreversible 
inhibitors tightly bind to the target enzyme, either covalently or noncovalently, and dissociate 
slowly from it. Reversible inhibition is when the inhibition of the enzyme is brief and the 
inhibitor dissociate fast. Competitive inhibition is when the inhibitor, which is similar to the 
substrate in structure, binds to the active site of the enzyme. The binding of the enzyme and 
substrate is thus prevented17. 
Mitogen-activated Protein Kinases 
Mitogen-activated protein kinases (MAPKs) family member phosphorylates Ser/Thr residues 
in the substrate molecules18. The MAPK family of protein kinases is further divided into two 
subfamilies, conventional MAPKs and atypical MAPKs (Figure 4). The conventional family 
consists of ERK1/2, JNK1-3, p38α, β, γ, δ and ERK 5. The atypical family consists of ERK3/4, 
NLK and ERK719,20. When a cell receives a stimuli the mitogen-activated protein kinase kinase 
kinases (MAPKKKs) phosphorylate mitogen-activated protein kinase kinases (MAPKKs), 
which then phosphorylate mitogen-activated protein kinases (MAPKs)19. The MAPKKKs, 
which themselves are Ser/Thr kinases, are activated by extracellular stimuli like mitogens, 
cytokines and cellular stresses. In response of these stimuli, MAPKKs become phosphorylated 
and/or interact with a small G protein of Ras/Rho family21,22. This leads to the phosphorylation 
of MAPKKs, which further activates the individual MAPK through dual phosphorylation on 
the specific Thr and Tyr residues found in their activation loop20. An illustration of the MAPKs 
demonstrates their general structures (Figure 3). 
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Figure 3 Schematic illustration of the general structures of MAPKs. Different lengths of N- and C-terminal regions flank 
the kinase domain, which binds to the MAPKs substrate and phosphorylate them at Ser/Thr domains. In some MAPKs, there 
are additional domains such as transactivation domain (TAD), nuclear localization sequence (NLS), region conserved in 
ERK3/4 (C34) and domain rich in alanine (Ala), histidine (His), and glutamine (Glu) (AHQr). The three amino acids segment 
for the phosphorylation of the MAPK above the kinase domain is also presented (Reprinted from 21). 
The atypical MAPKs mechanism is less known due to their divergent characteristic. They do 
not share the three-tiered kinase cascades. Moreover, a glycine (Gly) or glutamic acid (Glu) 
represents instead of the Tyr in the activation motif for ERK3/4 and NLK. ERK7 contains the 
motif Thr-Glu-Tyr motif rather than the Thr-X-Tyr, which presents in conventional MAPK 
pathway. Phosphorylation of Thr-Glu-Tyr is catalyzed by ERK7 itself instead of by an upstream 
MAPKK19.  
MAPKs phosphorylate their respective substrates. These include the members of a family of 
protein kinases called MAPK-activated protein kinases (MAPKAPKs) (Figure 4). This family 
includes the protein kinases; p90 ribosomal S6 kinases (RSKs), mitogen- and stress-activated 
kinases (MSKs), MAPK-interacting kinases (MNKs), MAPK-activated protein kinase 2/3 
(MK2/3), and MK521. 
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Figure 4 Signalling Patterns of MAPK-Pathway. The conventional MAPKs follow the three-tiered pathway, whereas the 
atypical MAPKs do not. The dotted lines indicate that it has been reported that RSKs and MK5 have been phosphorylated by 
their respective MAPKs, but it needs more reports on them (reprinted from 21).Structure 
Through crystallization of members of ERK1/2, p38 and JNK groups the MAPK domain 
structure has been understood. The crystallization was done alone or in combination with 
substrates, scaffolds, inhibitors and derived peptides from substrates or interacting partners23. 
MAPKs are made of two regions, an N-terminal region, which consists of β-sheets and two 
helices, αC and αL16, and a C-terminal region that is mostly helical, with four short β-strands. 
Between these two regions lies the catalytic site, where the ATP and two magnesium ions bind. 
In addition, a flexible linker, which functions as a connecting molecule, maintains the proper 
orientation of the terminal regions. Proper orientation is important for the enzymatic activity. 
The MAPK insertion, to be found in the C-terminal region and extend over the whole protein, 
including the αL16 helix, distinguishes MAPKs from other proteins on the kinase superfamily24 
(Figure 5). 
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Figure 5 Crystal structure of active ERK2. General structure of MAPKs with the MAPK insertion together with an extension 
of the C-terminal region distinguishes MAPKs from other proteins of the kinase superfamily. Ribbons colored according to 
their secondary structure, β-sheet in yellow, α-helices in purple and loops in cyan (Adapted by permission from Macmillan 
Publishers Ltd on behalf of Cancer Research UK: [MAP kinases and the control of nuclear events]24, copyright 2007). 
The Conventional MAPKs 
ERK1/2 
Extracellular signal-regulated kinase 1 and 2 (ERK1/2) are nearly 85% identical, with 43 and 
41 kDa respectively. They are activated through dual phosphorylation of tyrosine and threonine, 
which are separated by a glutamate residue to yield the motif TEY in the activation loop. Both 
kinases are vastly expressed in tissues. Stimuli like growth factors, cytokines and certain 
stresses activate the ERK1/2 signaling pathway20. Upstream of this cascade, the MAPKKKs 
phosphorylate two serine residues or a serine and a threonine to activate the MAPKKs MEK1/2. 
The Raf isoforms, a-Raf, B-Raf and C-Raf are the main MAPKKKs in ERK1/2 cascade. Mos, 
Tpl2, and other MAPKKKs are limited to certain cell type signaling22. Downstream, ERK1/2 
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phosphorylate many protein kinases, such as p90 ribosomal S6 kinase (RSK), mitogen and 
stress activated kinase (MSK), and the transcription factors Elk1, c-Fos, c-Myc, and Ets domain 
factors.  
JNK 
c-Jun N-terminal kinases (JNK) has three isoforms; JNK1, JNK2 and JNK3. They are more 
than 85% identical and exist as 10 or more spliced forms of 46 to 55 kDa. JNK1 and JNK2 are 
found in all tissues, while JNK3 is mainly in the brain22. Stimuli, such as cellular stresses, 
growth factors and cytokines activate the JNK pathway25. Upon activation, JNKs become 
phosphorylated at tyrosine and threonine residues, which are separated by a proline residue to 
give a TPY motif in the activation loop20. Upstream this cascade, the MAPKKKs MEKKs 
(MEKK1, -2, -3 and -4), mixed lineage kinases (MLKs), Tpl2, ASKs, TAOs and TAK1 
phosphorylate the MAPKKs MKK4 and MKK7. This phosphorylation takes place in the serine 
and threonine residues of MKK4/722. The transcription factors c-Jun, p53, JunB, c-Myc and 
ATF2 are among substrates of JNKs22,26. Studies indicate that the pro-apoptotic proteins BAX 
and BAK are substrates of JNKs and an in vitro study shows that the anti-apoptotic proteins 
BCL2, BCL-XL and MCL-1 are phosphorylated by JNKs27. The JNK pathway regulates 
mediation of cell proliferation, differentiation or apoptosis22. 
p38 
There are four isomers of the 38 kDa p38; α, β, γ, δ which have 60% identity among themselves. 
The p38 MAPK cascade is activated by stimuli such as cellular stressors (eg. UV radiation), 
osmotic shock, hypoxia, pro-inflammatory cytokines and growth factors. Dual phosphorylation 
and activation of p38 takes place in the TGY motif of the activation loop by the upstream 
MAPKKs MEK3 and -6. It has been shown that p38 is phosphorylated by MKK4, which is an 
enzyme in the MAPK JNK pathway in vitro28. p38α and –β exist in all tissues, while the γ and 
δ isomers are more limited to tissues22. MEK3/6 are phosphorylated by TAK1, TAO1/2, TPL2, 
MLK3, MEKK3/4 and ZAK1 in the serine/threonine site of the activation loop. Most of these 
MAPKKKs stimulate the JNK pathway28. Downstream the p38 cascade, p38s phosphorylate 
MSK1 and -2, and MK2 and -3. MSK1/2 are important for rapid induction of immediate-early 
genes, resulting from stress or mitogenic stimuli. MK2/3, in the other hand, play a role in the 
control of gene expression28. 
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ERK5 
Extracellular signal-regulated kinase 5 (ERK5) is of 88 kDa and is activated through 
phosphorylation on threonine and tyrosine residues of the Thr-Glu-Tyr motif in the activation 
loop. ERK5 is activated upstream in the cascade by MAPKK MEK5, which then becomes 
phosphorylated by MAPKKKs such as COT, MEKK3 and MEKK224. MEKK2/3 also stimulate 
the JNK and p38 pathways29,30. This pathway is activated by growth factors, oxidative stress 
and hyperosmolarity and plays a role in cell proliferation and survival. ERK5 phosphorylates 
MEF2C which belongs to myocyte enhancer factor 2 (MEF2) protein family, Sap1a, SGK, 
Cx43 and Bad031,32. It has been identified that ERK5 phosphorylates the RSK family of protein 
kinases33 
The Atypical MAPKs 
The ERK3/4 – MK 5 pathway 
Extracellular signal-regulated kinase 3 (ERK3) contains a C-terminal extension of 178 amino 
acids (aa), giving a protein with a molecular mass of ~100 kDa. Whereas ERK4 is a 578-aa 
protein with a molecular mass of ~70 kDA. ERK3 and ERK 4 possess 73% amino acid 
similarity. They are atypical because they lack the phosphoacceptor Tyr residue, which is 
present in the activation loop of conventional MAPKs21. The functions of ERK3/4 are little 
understood. ERK3 may play a role in the regulation of cell proliferation and differentiation34.  
ERK3/4 contain the sequence S-E-G instead of T-X-Y in their activation loop. The phospho-
acceptor in ERK (S189) and ERK4(S186) are phosphorylated in growing cells. Moreover, 
phosphorylation of these single serine phospho-acceptors are required for their ability to 
activate MK5 in vitro and form stable and active complexes with MK5 in mammalian cells. 
This phosphorylation in the activation loop of ERK3/4 for binding and activation of MK5 
differs from interactions between classical MAPKs and their substrates, such as MK2 and MK3, 
in that these bind through the so called common docking domain and hence, can occur 
independently from the activation loop phosphorylation35.  
One known substrate of ERK3/4 is the MAPK-activated protein kinase MK5. There are 2 
isoforms, 471 and 473 aa, but the importance of having 2 almost alike molecules remain 
unclear. When MK5 is overexpressed, its concentration is highest in the nuclei of quiescent 
cells. Upon cellular stress, the concentration is highest in the cytoplasm 21. No extracellular 
stimuli have not been discovered yet for ERK3 and ERK4, thus the connection between and 
endogenous MK5 and the extracellular stimuli remains questioned35. 
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MK5 
MAPK-activated protein kinase (MK5) had its first name as the acronym PRAK (p38-
regulated/activated protein kinase) because it was described as a serine/threonine protein kinase 
downstream target of the p38 MAPK-pathway. Upon activation of MK5 through binding with 
ERK3/4, MK5 translocates from cell nucleus to the cytoplasm. Despite MK5 being activated 
by both p38 α/β and atypical ERK3/4, only ERK3/4 have been found, when overexpressed in 
mammalian cells, to form endogenous complexes with MK535. Sun et al. shows that MK5 plays 
a role in Ras-induced senescene in primary murine fibroblasts in the p38-MK5 signaling 
pathway. When Ras is activated, the p38-MK5 pathway stimulates the transcription of the 
tumour suppressor protein p53, which lead to increased level of the p21 protein in the cells. On 
the other hand, there is strong evidence that the serine 37 within the activation domain of p53 
is phosphorylated by MK5.  
MK5 and Cancer 
Recently, studies of MK5 have been done to define the role of MK5 in the pathology of cancer. 
Evidences from these studies suggest that MK5 behaves either as a tumour suppressor or a 
tumour promoting, depending on the cell type or the stage of cancer at which it is activated.  
Interactions between ERK3/4 and MK5 
MK5 contains a conserved LXTP site in the activation loop where the threonine is the only 
phospho-acceptor site. It contains a functional nuclear export sequence (NES) and a nuclear 
localization sequence (NES) within the C-terminal domain, where NLS overlaps with the 
MAPK docking site. Furthermore, MK5 has a 100 amino acid extension C-terminal to the NLS. 
This sequence, which cannot be found in MK2 and MK3, contains amino acids that are required 
for interaction with ERK3/436. The ERK3 and ERK4 interaction domain is termed the FRIEDE-
motif after Aberg et al.37.  
 
Figure 6 Schematic structure of MK5. Phospho-acceptor site at amino acid threonine 182 (T182). The Nuclear Export Signal 
(NES), Nuclear Localization Signal (NLS) and ERK3 and ERK4 interaction domain (FRIEDE) are shown. (Adapted from 36). 
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Aim of Thesis 
In this study, we wanted to express and purify full-length and different domains of the mitogen-
activated protein kinase 5, a substrate of ERK4 in E. coli. 
The purified MK5 will be used to gain structural information of the kinase in experiments to 
reveal how MK5 physically interacts with ERK4. 
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MATERIALS 
Chemical Reagents 
I. Restriction 
10x NEBuffer 2 New England Biolabs® inc, USA 
10x NEBuffer 2.1 New England Biolabs® inc, USA 
 
II. Gel Electrophoresis 
Ethidium Bromide 10 mg/ml Sigma-Aldrich®, USA 
1 Kb plus DNA ladder Invitrogen, Carlsbad, USA 
Seakem® LE Agarose Lonza Group, Switzerland 
Seakem® GTG Agarose Lonza Group, Switzerland 
1xTAE buffer 40 mM Tris-acetate 
1 mM Tris-acetate 
1 mM EDTA 
6x loading buffer 0.03% Bromphenol blue 
0.03% Xylene cyanol FF 
10 nM Tris HCl pH=8 
60% Glycerol 
 
III. Sequencing 
5x Phusion® 
reaction buffer 
 New England 
Biolabs® inc, 
USA 
F Primer (MK5) CCTTTACTTCCAGGGGATGTCGGAGGAGAGCGACATGG Sigma-
Aldrich®, 
USA 
R Primer (MK5) GCTTGAATTCGGATCCTTATTGGGATTCGTGGGACG Sigma-
Aldrich®, 
USA 
F Primer (Vector) CGTCCCACGAATCCCAATAAGGATCCGAATTCAAGC Sigma-
Aldrich®, 
USA 
R Primer 
(Vector) 
CCATGTCGCTCTCCTCCGACATCCCCTGGAAGTAAAGG Sigma-
Aldrich®, 
USA 
Deoxynucleotide 
Mix, 10mM 
 Sigma-
Aldrich®, 
USA 
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IV. Reagents for Bacteria and Transformation 
Lysogeny Broth (LB) University hospital in Northern Norway 
(UNN), Tromsø: 
10 g/l Bacto tryptone (DIFCO) 
5 g/l Bacto yeast extract (DIFCO) 
171 mM NaCl 
pH adjusted to 7.4 
Prepared with the appropriate antibiotic 
LB-agar plate University hospital in Northern Norway 
(UNN), Tromsø: 
10 g/l Bacto tryptone (DIFCO) 
5 g/l Bacto yeast extract (DIFCO) 
171 mM NaCl 
pH adjusted to 7.4 
10 g/l agar 
Prepared with the appropriate antibiotic 
S.O.C. medium 2% Tryptone 
0.5% Yeas extract 
10 mM NaCl 
2.5 mM KCl 
Sterile solution of 10 mM MgCl2 and 20 mM 
Glucose  
1 M Isopropyl-β-D-thiogalactopyranosid 
(IPTG) University hospital in Northern Norway 
(UNN), Tromsø: 
Terrific Broth (TB) medium University hospital in Northern Norway 
(UNN), Tromsø: 
For 1 l medium: 
12 g/l Tryptone 
24 g/l Yeast extract 
100 ml sterile solution of 0,17 M KH2PO4 
and 0,72 M K2HPO4 
Prepared with the appropriate antibiotic 
 
V. Buffers 
10x T4 DNA Ligase buffer New England Biolabs® inc, USA 
Odyssey® Blocking Buffer LI-COR, Lincoln, Nebraska USA 
Blotting buffer 29 g Tris base 
144 g glycine 
1 l methanol 
Adjusted to 5 l with dH2O 
Buffer A  University of Tromsø, Pharmacology 
Research group: 
50 mM NaH2PO4, pH=8 
500 mM NaCl 
Lysis buffer A University of Tromsø, Pharmacology 
Research group: 
50 mM NaH2PO4, pH=8 
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500 mM NaCl 
1 tablet of cOmplete, Mini, EDTA-free 
proteinase inhibitor (Sigma-Aldrich) 
Lysozyme from chicken egg white (Sigma-
Aldrich) 
2-4mM β-mercaptoethanol 
Elution buffer B University of Tromsø, Pharmacology 
Research group: 
50 mM NaH2PO4, pH=8 
300 mM NaCl 
500 mM Imidazole 
2-4 mM β-mercaptoethanol 
Dialysis buffer A University of Tromsø, Pharmacology 
Research group: 
50 mM Tris pH=7.5 
200 mM NaCl 
2 mM β-mercaptoethanol 
Dialysis buffer B University of Tromsø, Pharmacology 
Research group: 
50 mM Tris pH=7.5 
150 mM NaCl 
2 mM β-mercaptoethanol 
Gel filtration buffer University of Tromsø, Pharmacology 
Research group:  
50 mM Tris pH=7.5 
150 mM NaCl 
4 mM β-mercaptoethanol 
Filtered 
MAPKK lysis buffer 8 ml tris, pH= 7.0 
4 ml Triton X-100 
8 ml 250 mM NaPPi 
40 ml 500 mM NaF 
0.8 ml 0.5 M EDTA 
0.8 ml 0.5 M EGTA 
2 ml 200 mM VO4 (Ortovanadate) 
216 ml 0.5 M Sucrose 
8 ml 500 mM β-glycerophosphate 
112.4 ml MQ water 
1 dissolved tablet of cOmplete™, EDTA-free 
Protease inhibitor cocktail in 10 ml buffer 
 
VI. Antibiotics 
Ampicillin Conc. used: 100 µg/ml, Sigma-Aldrich®, 
USA 
Chloramphenicol Conc. used: 34 µg/ml, Sigma-Aldrich®, 
USA 
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VII. Cell Culture and Transfection Reagents 
1x Dulbecco’s phosphate buffered saline (PBS) Sigma-Aldrich®, USA 
0.25% Trypsin-EDTA solution Sigma-Aldrich®, USA 
Opti-MEM® 1x, reduced serum medium Thermo Fisher Scientific, USA 
Lipofectamine® 2000 Transfection Reagent Invitrogen, Carlsbad, USA 
 
VIII. Cell Culture Media and Cells 
Cells  Growth Medium Supplements 
A549 Dulbecco’s modified eagle’s 
medium, D5796; Sigma-
Aldrich®, USA  
10% Fetal bovine; Biochrom 
GmbH, Berlin, Germany 
1% Penicillin-Streptomycin 
10,000 U/ml 
 
IX. SDS-PAGE 
10x Bolt® Sample reducing agent Invitrogen, Carlsbad, USA 
4x NuPAGE® LDS sample buffer Invitrogen, Carlsbad, USA 
Bolt® 4-12% Bis-Tris Gel 1.0mm x 10/12 
wells 
Invitrogen, Carlsbad, USA 
1x SeeBlue® Plus2 pre-stained protein 
standard 
Invitrogen, Carlsbad, USA 
1x NuPAGE® MES SDS Running buffer Invitrogen, Carlsbad, USA 
1x TBS-T University of Tromsø, Pharmacology 
Research group: 
0.1% Tween 20 
10x TBS: 10 g KCL 
400 g NaCl 
200 ml 1 M TrisCl pH= 7.5 
Adjusted to 5 l with dH2O 
MagicMark™ XP Western Protein Standard Invitrogen, Carlsbad, USA 
PageBlue™ Protein Staining Solution Thermo Fisher Scientific, USA 
X. Blotting 
10x TBS  10 g KCl 
400 g NaCl 
200 ml 1 M Tris-HCL, pH=7.5 
Adjusted to 5 l with dH2O 
1x TBS-T 1x TBS 
0.1% Tween 20 
Tween® 20 Sigma-Aldrich®, USA 
 
XI. Protein Purification 
β-Mercaptoethanol AppliChem GmbH, Darmstadt, Germany 
Ni-Nta Agarose QIAGEN Gmbh, Germany 
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Amicon Ultra-15 Centrifugal Filter Unit with 
Ultracel-3 membrane 
Merck Millipore, a part of KGaA, Darmstadt, 
Germany 
PBS Dulbecco w/o Ca2+, w/o Mg2+ powder Biochrom GmbH, Berlin, Germany 
Glutathione Sepharose 4 Fast Flow GE Healthcare Life Sciences, Oslo, Norway 
XII. GST Pulldown Assays 
Pierce™ Gluthatione Agarose Thermo Fisher Scientific, USA 
 
Enzymes 
I. Restriction Enzymes 
NdeI New England Biolabs® inc, USA 
XhoI New England Biolabs® inc, USA 
DpnI New England Biolabs® inc, USA 
BamHI New England Biolabs® inc, USA 
 
II. Ligation Enzymes 
T4 DNA Ligase New England Biolabs® inc, USA 
 
III. Polymerases 
Phusion® High-Fidelity DNA polymerase New England Biolabs® inc, USA 
 
Vectors and Plasmids 
I. Expression Vectors 
pET-15b University of Tromsø. Pharmacology 
Research group 
pColdII University of Tromsø. Pharmacology 
Research group 
Gateway® pDEST™15 Vector 
 
Thermo Fisher Scientific, USA 
Gateway® pDEST™17 Vector 
 
Thermo Fisher Scientific, USA 
II. Cloning Vectors 
Dh5α University of Tromsø. Pharmacology 
Research group 
 
Materials 
17 
 
III. Plasmids 
MK5 University of Tromsø. Pharmacology 
Research group 
MK5 (372-472) University of Tromsø. Pharmacology 
Research group 
MK5 (383-472) University of Tromsø. Pharmacology 
Research group 
TEV University of Tromsø. Pharmacology 
Research group 
pEGFP-MK5 372-473 University of Tromsø. Pharmacology 
Research group 
pEGFP-MK5 383-473 University of Tromsø. Pharmacology 
Research group 
pEGFP-MK5 University of Tromsø. Pharmacology 
Research group 
ERK4 University of Tromsø. Pharmacology 
Research group 
ERK4 S186A University of Tromsø. Pharmacology 
Research group 
ERK4-FLAG University of Tromsø. Pharmacology 
Research group 
Kits 
QIAquick® Gel Extraction Kit QIAGENT Gmbh, Germany 
QIAgen® Plasmid Plus Midi Kit QIAGENT Gmbh, Germany 
QIAprep® Spin Miniprep Kit QIAGENT Gmbh, Germany 
 
Bacteria 
Dh5-α Competent E. coli University of Tromsø, Pharmacology 
Research group (see protocol38) 
BL21(DE3)-CodonPlus-RIL Competent 
Cells 
University of Tromsø. Pharmacology 
Research group 
Antibodies 
Primary antibodies 
 
His-ERK4 antibody Dundee, Scotland 
Anti-MK5 P-T182 (3. Bleed 0.21 mg/ml) Dundee, Scotland 
Anti-MK5 P-T182 (1. Bleed 0.12 mg/ml) Dundee, Scotland 
Anti-MK5 P-T182 (3. Bleed 0.13 mg/ml) Dundee, Scotland 
GST antibody (Z-5): Sc-459 Santa Cruz Biotechnology, Texas, USA 
Secondary antibodies 
 
Donkey anti-Sheep IgG (H+L) Secondary 
Antibody, Alexa Fluor® 680 conjugate 
Invitrogen, Carlsbad, USA 
IRDye® 800CW Donkey anti-rabbit igG 
(H+L), 0.5 mg 
LI-COR, GmbH, Germany 
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Instruments and Machines 
PCR machine MJ Research PTC-200 Peltier Thermal 
Cycler DNA Engine, Waltham, USA 
Incubator for bacteria plates Termaks, Bergen, Norway 
Shaker for bacteria cultures Unitron HT InforsAG, Bottmingen, 
Switzherland 
Water bath 42°C Grant Y6 Instruments, Cambridge, USA 
Vortex machine Labnet VX100 Vortex, MO BIO, Carlsbad, 
USA 
Centrifuge Thermo scientific PICO 21 Heraeus, Thermo 
Scientific, Waltham, USA 
Nanodrop machine NanoDrop® ND-1000 Spectrophotometer, 
Wilmington, USA 
Agarose gel chamber BIO-RAD POWER PAC 3000 
UV light UV Transilluminator UVP Model M-15, CA, 
USA 
Machine for visualization of stained agarose 
gels 
Gel Doc 2000 BIO-RAD, Hercules, USA 
Mammalian cells incubator Thermo Scientific Heracell 150i, CO2 
Incubator, 37°C , 5% CO2, Waltham, USA 
Shaker Heidolph Unimax 2010, Schwabach, 
Germany 
Bolt® Mini Gel Tank Invitrogen, Carlsbad, USA 
Centrifuge for larger culture protein Sorvall RC-3C centrifuge 
Sonicator for larger culture protein SONICS Vibra cell VCX 500 
Roller mixer Analogue tube roller- SRT6 
High speed centrifuge (25,000 rpm) Beckman Coulter Avanti J-25 
Magnetic stirrer  Heidolph MR 3001 
Machine for infrared detection of Western 
blots 
The Odyssey® Sa Infrared Imaging System 
Automatic sonicator Bioruptor, Diagenode, Seraing, Belgium 
Manually sonicator Microson™ Ultrasonic Cell Disruptor 
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METHODS 
There are many steps involved in expression of protein of interest. For each step in the protocol 
there are choices to be made regarding the specific protocol. Here the protocols are presented 
chronologically. 
The aim of the project was to modulate the activity of MK5. For that the protein itself had to be 
made. For this to happen, a cloning procedure had to be done, either by restriction enzyme 
based subcloning or “fast cloning” using polymerase chain reaction (PCR). 
Construction of MAP Kinase 5 (Subcloning) 
Subcloning is the process of insertion of a DNA fragment from one to another39. The DNA 
fragment and vector of interest are cut with restriction endonucleases. They are then purified 
by agarose gel electrophoresis, and treated with DNA ligase to bind the sticky ends of the 
fragment to the vector. The ligation products are introduced into Escherichia coli cells. The 
cells are then plated with the appropriate antibiotic before DNA from the colonies are being 
purified and cut with restriction enzymes. A separation technique, called agarose gel 
electrophoresis separates the DNA fragments from the cut DNA. Hence, the DNA of interest 
can be confirmed40. 
Restriction 
DNA restriction is a technique used for molecular cloning, either by polymerase chain reaction 
(PCR) or subcloning. It is also used in diagnostic testing to verify the insert of interest41. For 
this to happen restriction enzymes are required. They are also called restriction endonucleases 
because of the cutting within the DNA. Each endonuclease recognizes specific DNA sequences 
(usually palindromic). The recognition sequence range from 4-8 nucleotides. Since each 
endonuclease is different, there are various conditions to ensure their optimal activity, such as 
temperature, pH, enzyme cofactor(s), salt composition and ionic strength42,43.  
With DNA restriction method, one can for example with two restriction endonucleases cut and 
give two different ends for the insert. The insert will then orientate with the compatible ends in 
the vector due to ligation. Novel constructed plasmids will be made. On the other hand, this 
method can be used to find out if the new constructed plasmids really have been made. The cut 
DNAs are to be analyzed visually on agarose gel. 
Generally the restriction was performed using these steps: 
1 µg DNA 
Methods 
20 
 
Mix of: 
 
The sample was mixed carefully and incubated at 37°C for 1-2 hours. 
For this study, the plasmids were cut with the restriction enzymes NdeI and XhoI with NEBuffer 
2. 
Gel Electrophoresis 
The DNA fragments, which are cut by restriction enzymes are separated by means of agarose 
gel electrophoresis. The gel act like retentive filter for negative charged fragments which could 
be resolved by range from ~0.5 to 25 kb for standard agarose. The fragments start near negative 
pole and migrate to positive one. Hence the smaller fragments will migrate faster and be nearer 
to the positive pole44,45.  
- 1% agarose gel was prepared by dissolving 0.5 or 1 g Seakem® GTG Agarose, 
depending on how many samples that were run, in 50 or 100 ml 1x TAE buffer under 
heating. 
- 0.2-0.5 µg/ml of ethidium bromide 10mg/ml solution was then added. Ethidium is a 
DNA intercalating agent, and fluoresces under UV light. 
- The gels was poured into the chamber with a comb on top of it. The comb makes small 
pockets in the gel, so samples can be loaded in them. 3 µl of 6x loading buffer was 
mixed to each sample and put in each comb. 
- 6x loading buffer contains dye and glycerol, this makes the sample visible and heavier 
than water so that the sample can be followed. 
- The gel ran for 90V in approximately 45 minutes with in 1x TAE buffer. 8 µl 1 kb plus 
ladder serves as a reference because of the known molecular weight for each bands it 
presents46. 
- After the gel was run, the DNA fragment was excised with a scalpel under low doses of 
UV-light to minimize the damage of DNA. 
- The gel fragment was then purified with QIAquick® Gel Extraction Kit. 
Gel electrophoresis can also be used to separate DNA for qualitative analysis. Here Seakem® 
LE Agarose was used under the same conditions. The result was analyzed in Gel Doc 2000 UV 
transilluminator (Bio-rad®, Norway) with the Quantity One 4.30 software (Bio-rad®, Norway), 
using UV-light. 
1 µl of restriction enzyme 
Appropriate buffer for the endonuclease(s) for optimized cutting 
Purified water up to volume 20 µl, depending on volume of DNA to be cut 
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- 0.5g Seakem GTG Agarose was dissolved in 50ml TAE buffer and 20 µl ethidium 
bromide 1 mg/ml was added. 
- The samples with vector pEt-15b and insert GAD-MK5 were added with 3 µl Gel 
Loading Dye (6X). 10 µl 1 Kb Plus DNA Ladder was used. 
- Gel was run for approximately 40 minutes. 
Bands of 5.5 kb for pET-15b and 1.5 kb for GAD-MK5 were extracted and purified using 
QIAquick® Gel Extraction Kit47. 
Ligation 
Ligation enzymes exist to join Okazaki fragments during DNA replication and to repair 
stranded nick in DNA48. The enzymes join the 3’-hydroxyl end of one nucleotide to the 5’-
phosphate end of another one. This property can be used to form new plasmids. T4 ligase was 
used in this study and uses ATP as a cofactor49. 
Mix of:  
 
Incubated at 24°C for two hours. Vector alone + ligase control was done for every ligase 
reaction, to verify the if the vector and DNA insert were cut during the restriction step. 
Control: 
 
Incubated for 2 hours at 24°C. 
Transformation into DH5α cells 
Transformation is a process of inserting DNA into bacteria cell. The first transformation was 
carried out by Avery50. The DNA can only be replicated if it contains an origin of replication, 
OriC, recognized by the polymerases of the bacteria cells. A DNA sequence encoding for 
antibiotic resistant allows the cloning and isolation of plasmid DNA in the bacterial cells when 
plated51.  
In order for the competent cells to uptake DNA, they have to be heat shocked at 42°C. 
Day 1 
- 50 µl of DH5α cells was thawed in ice for ~20 minutes52. 
2 µl purified cut vector 
6 µl DNA template 
1 µl 10x T4 ligase buffer 
1 µl ligase 
2 µl  purified cut vector 
6 µl purified water 
1 µl 10x T4 ligase buffer 
1 µl ligase 
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- Then 1 µl plasmid was added and incubated for ~20 minutes in ice. 
- The mix heat shocked for 90 seconds and was followed by 2 minutes in ice. 
- 50 µl of the transformation mix was plated out on LB plates with appropriate antibodies. 
- The plates incubated overnight in 37°C. 
Day 2 
- One grown colony was inoculated in 3 ml LB medium with selection antibiotic and 
incubated at 37°C with shaking. 
Day 3 
- Bacteria cells were harvested by centrifugation. 
- To isolate and purify the DNA plasmids, QIAprep® Spin Miniprep Kit was used53. 
Strong alkaline with SDS solution was used to lysis and denature the bacterial 
membrane and DNA. 
- The DNA was bound to the column. 
- It was then washed with several steps before the DNA was eluted.  
- For control if the DNA was successful generated, the plasmid was cut with the same 
enzymes which yield matching ends during ligation.  
- An analytical agarose gel was run to confirm the outcome. 
Construction of MAP Kinase 5 (FastCloning) 
FastCloning is a cloning method that is generated by Li et al54. It excludes the need of joining 
the insert and vector by T4 DNA ligase after restriction, which has multiple steps and is time 
consuming. Therefore, this technique makes it easy to make constructs for fusion proteins and 
chimeras, along with making short insertions and mutation up to 120bp in cDNA. FastCloning 
uses Polymerase Chain Reaction as a foundation before the products are digested with DpnI 
restrion enzyme. Eventually, the mix of vector and insert are transformed in competent cells for 
protein expression.  
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Figure 7 Illustrated overview of FastCloning. Step 1: PCR amplification of vector and insert. Step 2: DpnI digestion. Step 
3: Transformation into competent cells (reprinted from 54) 
The Polymerase Chain Reaction 
The polymerase chain reaction was developed by Kary Mullis in 198355. It is a method for 
cloning DNA segments of interest without restriction digestion. With the use of primers, which 
are short single-stranded DNAs with any kind of sequences combination, one can determine 
which DNA segments in the genome to be copied. Through complementary base pairing, one 
primer attaches to the start on one end of the DNA strand. The other primer, reverse primer, 
attaches to the end on the other end of the DNA strand. Primers are starting point for DNA 
polymerases to start copying. When a DNA polymerase combines with a base pair complex of 
the primer and DNA strand, it starts adding nucleotides homologous to the DNA sequences. 
Nucleotides are the building blocks in the PCR reaction. A mixture of four types of nucleotides 
exist in the liquid together with the primers and polymerase – A’s, C’s, G’s and T’s56, also 
known as deoxynucleoside triphosphates (dNTPs)56. 
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For synthesis of new DNA sequences, the origin DNA template has to denature into two single-
stranded DNA (ssDNA)57. This is done by heating the samples. Primers can then anneal to the 
each of the ssDNA complementary to their 5’  3’ ends. This is where polymerases can start 
extending new DNA strands d. The process of denaturation, annealing and extension go in 
cycles of 20-30. For every cycle, new strands of DNA are synthesized exponentially. 
Eventually, 30 cycles will yield 228-fold amplification of the DNA segments of interest (Figure 
8). 
 
Figure 8 Polymerase chain reaction overview. Template DNA with the target sequence denatures at 94-96°C before primers 
bind to sense and antisense of the target sequence. Annealing takes place and polymerase of interest synthesize new nucleotides 
complementary to the ssDNA. After 2nd cycle, two discrete DNA segments generates (reprinted from 58).  
For both MK5 insert and  vector separately: 
Component 50 µl reaction Final concentration 
5x Phusion GC Buffer 10 µl 1x 
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10 µM dNTPs 1-2 µl 200-400 µM 
10 µM Forward Primer 1 µl 0,5 µM 
10 µM Reverse Primer 1 µl 0,5 µM 
Template DNA 20-150 ng Variable |<250 ng 
Phusion Polymerase 0,5-1 µl 1,0-2,0 units/50 µl PCR 
Nuclease free water To 50 µl  
 
PCR program: 
1 cycle 3 min at 98°C Initial denaturation 
 15 sec at 98°C  
18-20 cycles 30 sec at 55°C Denaturation, annealing and extension 
 30 sec/kb at 72°C  
1 cycle 10 min at 72°C Final extension 
 
- 5 µl of each PCR product was for routine examination with 1% agarose gel 
electrophoresis. 
Digestion with DpnI and Transformation 
- 1 µl DpnI was added into the remaining 45 µl for insert and vector separately. 
- The vector and insert were then mixed with 1:1 ratio, and digested at 37°C for 1 hour. 
- 3 µl vector-insert mixture were then added to 50 µl of competent DH5α E.coli cells. 
- The mixture was then incubated for 30 min on ice. 
- After heat shock at 42°C for 45 sec, 300 µl of SOC medium was added to the mixture. 
- The mixture incubated at 37°C for 1 hour with shaking at 225 rpm. 
- The entire content was plated onto LB agar plate containing 100 µg/ml ampicillin.  
- The plate was then incubated at 37°C overnight.  
- Next day, colonies were picked for verifying with restriction digestion with BamHI: 
Construction of MAPK Kinase 5 Domains 
By the means of “Gateway” recombination system, the amino acids 372-473 and 383-473 of 
MK5 was generated. “Gateway” recombination cloning system is a one-hour recombination 
reaction with several benefits. It does not use restriction enzymes, ligase and screening of 
colonies. The method involves two steps. These are: 1) Determination of the Entry clone that 
contains the DNA insert flanked by attL sequences, which could be recombined with attR 
sequences in the expression vector; 2) Mediating the reaction with LR Clonase enzymes, which 
catalyze the reaction between attL and attR sequences so that the DNA insert is integrated in 
the destination vector, the expression vector. Once the Entry clone is determined, i.e. the DNA 
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insert in a “Gateway” vector, the gene of interest can be shuttled between any other vector of 
interest according to which study to conduct59. Here our genes of interest were recombined in 
vectors for protein expression in E. coli. 
- pDEST15 and pDEST17 were used as destination/expression vectors. 
- The vectors were transformed into DH5α cells. 
Transformation with BL21(DE3)-CodonPlus-RIL Cells 
Competent BL21(DE3)-CodonPlus-RIL cells are different than competent DH5α cells, in that 
they are suitable for protein expression60. They contain plasmids that encode arginine, 
isoleucine and leucine tRNAs which are rare in E.coli, but common in human proteins. 
Moreover, BL21 strains do not express the proteases ompT and lon, which degenerate 
recombinant protein expression effencieny61. 
Transformation of MK5-HIS, MK5-HIS 372-473, MK5-GST 383-472 and TEV was done into 
BL21(DE3)-CodonPlus-RIL competent cells, which have resistant genes for chloramphenicol. 
This yields a more specific isolation of competent cells of interest62. 
- One positive sample of 2 µl was transformed into 50 µl BL21(DE3)-CodonPlus-RIL 
cells. 
- The BL21(DE3)-CodonPlus-RIL cells were thawed in ice for 20 minutes before it was 
mixed with the DNA. 
- The mix was placed on ice for 20 minutes, heat shocked for 30 seconds and put back on 
ice for 2 minutes. 
- 300 µl SOC medium was then added to the mix and grew in 37°C shaking incubator, 
225 rpm for 45 min. 
- The mix was plated on LB plate with 100 µg/ml ampicillin and incubated at 37°C 
overnight. 
Quantification of DNA and Protein 
In order to determine the concentration of DNA from Miniprep or protein from purification, 
Nanodrop® ND-1000 spectrophotometer (Thermo Fisher Scientific, USA) was used. For DNA 
the spectrophotometer measures absorbance at the wavelengths 230, 260, which is the nucleic 
acids’ wavelength, and 280 nm. The purity was assessed with the ratio between these 
wavelengths. For proteins the samples are absorbed at 260 and 280 nm. The wavelength for 
proteins is 280 nm. 2 µl was used each time for measuring63. 
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Full-length MK5, MK5 fragments and TEV Protease Small-Scale 
Expression 
During this step, many experiments were conducted with different conditions for best protein 
expression in order to get the most soluble proteins for further studies. 
Overnight culture and Protein Expression 
Table 1 Conditions of MK5-HIS5 ( expression optimization) 
Trials of MK5-HIS 1 2 
Dilution 2:100 2:100 
Temp during protein 
expression 
28°C 24°C 
Sonication 3 x 10 sec (Microson™ 
Ultrasonic Cell Disruptor) 
5 min, 30 sec on and off 
(Bioruptor) with 1,5ml 
microcentrifuge tubes 
 
Table 2 Conditions of TEV protease (expression optimization) 
Trials 
of TEV 
proteas
e 
1 2 3 4 5 6 
Dilutio
n 
2:100 2:100 2:100 2:100 2:100 2:100 
Temp 
during 
protein 
express
ion 
37°C 37°C 37°C 24°C 24°C 24°C 
Sonicat
ion 
5 min, 30 
sec on and 
off 
(Bioruptor) 
with 1,5 
microcentri
fuge tubes 
5 min, 30 
sec on and 
off 
(Bioruptor) 
with 1,5 
microcentri
fuge tubes 
5 min, 30 
on and off 
(Bioruptor)  
with 1,5 
microcentri
fuge tubes 
5 min, 30 
sec on and 
off 
(Bioruptor) 
with 1,5 
microcentri
fuge tubes 
5 min, 30 
sec on and 
off 
(Bioruptor) 
with 1,5 
microcentri
fuge tubes 
5 min, 30 
sec on and 
off 
(Bioruptor) 
with 1,5 
microcentri
fuge tubes 
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Table 3 Conditions of MK5-HIS 372-473 (expression optimization) 
Trials of MK5-
HIS 372-473 
1 2 3 4 
Dilution 2:100 2:100 2:50 2:50 
Temp during 
protein expression 
37°C 24°C 24°C 37°C 
Sonication 3 x 10 sec 
(Microson™ 
Ultrasonic Cell 
Disruptor) 
6 x 10 sec 
(Microson™ 
Ultrasonic Cell 
Disruptor) 
6 x 10 sec 
(Microson™ 
Ultrasonic Cell 
Disruptor) 
6 x 10 sec 
(Microson™ 
Ultrasonic 
Cell 
Disruptor) 
 
Table 4 Conditions of MK5-HIS 383-473 (expression optimization) 
Trials of MK5-HIS 383-473 1 
Dilution 2:100 
Temp during protein 
expression 
37°C 
Sonication 3 x 10 sec (Microson™ 
Ultrasonic Cell Disruptor) 
 
Table 5 Conditions of MK5-GST 372-473 (expression optimization) 
Trials of MK5-GST 372-473 1 
Dilution 2:100 
Temp during protein 
expression 
37°C 
Sonication 6 x 10 sec (Microson™ 
Ultrasonic Cell Disruptor) 
 
Table 6 Conditions of MK5-GST 383-473 (expression optimization) 
Trials of MK5-GST 383-473 1 
Dilution 2:100 
Temp during protein 
expression 
37°C 
Sonication 6 x 10 sec (Microson™ 
Ultrasonic Cell Disruptor) 
 
- One colony was inoculated in LB medium with 100 µg/ml ampicillin for MK5-HIS. For 
MK5 fragments and TEV protease, colonies were inoculated in LB medium with 100 
µg/ml ampicillin and 34 µg/ml chloramphenicol. 
- Next day the cultures were diluted (see tables above) in their respective medium. 
- The cultures were let growth to OD600 of 0,6-1 at 37°C with shaking at 225 RPM.  
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- One sample was taken frequently to check the absorbance.  
- IPTG was then added 1:1000 to the culture was shaken at 225 rpm at designated 
temperature (see above).  
- 5 ml was sampled every hour up to 5 hours and overnight, total of 6 samples. Total 
lysates were sampled before IPTG induction and after overnight.  
- The samples except the total lysates were spinned down 20 min at 4000 RPM, 4°C and 
the supernatants were removed. 
- The pellets were resuspended in 500 µl TBS-T and sonicated (see above conditions). 
- The samples were then centrifuged at 4°C 10 min, 10.000 RPM.  
- The supernatants were transferred to new Eppendorf tubes, and both the pellets and 
supernatants were prepared for sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). 
SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis is a method for separating proteins 
by mass and their purity. The proteins wander from negative cathode to positive anode via pores 
in a gel matrix. The pores size decrease with the wandering towards the anode because of higher 
acrylamide concentrations. The results of gel pore size and protein size, charge, and shape 
determines the wandering rate of the protein. SDS is used to denature the protein prior to gel 
electrophoresis64. 
- For each supernatant samples, 39 µl supernatant was mixed with 15 µl 4x LDS buffer 
and 6 µl 10x reducing agent.  
- 50 µl 4x LDS buffer, 40 µl H2O and 10 µl 10x reducing agent were added into each 
pellet instead. 
-  The supernatant samples were heated 70°C for 10 minutes. Pellet samples were heated 
90°C for 10 minutes. This is to shake up the hydrophobic interactions between the 
molecules within the proteins.  
- The samples were run with 1x MES buffer on Bolt™ 4-12% Bis-Tris Plus Gel, 10 well. 
SeeBlue® Plus2 Pre-Stained Standard was used to visualize the protein molecular 
weight ranges during electrophoresis.  
- The gels were then analyzed Gel Doc 2000 UV transilluminator (Bio-rad®, Norway) 
with the Quantity One 4.30 software (Bio-rad®, Norway), using UV-light. 
Methods 
30 
 
MK5 and MK5 Fragments Protein Expression 
Conditions Medium Resuspension solution Induction 
temperature 
MK5-HIS TB + 100 µg/ml AMP + 
34 µg/ml CAM 
15 ml Lysis buffer A 24°C 
MK5-HIS 372-
473 
LB + 100 µg/ml AMP + 
34 µg/ml CAM 
15ml buffer A + 1 
dissolved tablet of 
cOmplete™, EDTA-free 
Protease inhibitor 
cocktail + 1:1000 β-
mercaptoethanol 
24°C 
MK5-GST 383-
473 
LB + 100 µg/ml AMP + 
34 µg/ml CAM 
40 ml PBS solution + 
1:1000 β-
mercaptoethanol + 1 
dissolved tablet of 
cOmplete™, EDTA-free 
Protease inhibitor 
cocktail 
37°C 
 
- One colony was picked for 51 ml starter culture in LB medium with 100 µg/ml 
ampicillin and 34 µg/ml. 
- Next day the starter culture was diluted 1:20 in 2 2L erlenmeyer flasks á 500 ml TB 
medium with 100 µg/ml ampicillin and 34 µg/ml. 
- Both flasks were then incubated till OD600 of ~1.00 with shaking in 37°C, samples was 
taken frequently to check the absorbance. 
- 1mM IPTG was added and induced for 3-5 hours according to the optimization 
conditions. The protein solutions were then harvested. 
- The protein solutions were then centrifuged for 30 min 10°C at 4.500 RPM using Sorvall 
RC-3C centrifuge, the supernatants trashed and flasks with pellets were put in -20°C 
freezer. 
- Next day the pellets were resuspended in their appropriate medium (see table above). 
- The solutions were then sonicated on ice with Sonics Vibra cell VCX 500 with 
following settings: 
Duration 20 min 
Temperature 12°C 
Pulse 5 sec 
Break 5 sec 
Amplitude 50% 
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- After sonication the solutions were centrifuged for 30 minutes, 25.000 RPM (rotor JA 
25.50) at 4°C with Beckman Coulter Avanti J-25.  
- The lysates with dissolved proteins were collected for purification. 
Protein Purification 
In order for further assays of MK5-proteins, they have to be as pure as possible so the impurities 
do not interfere with the actual results. For this purpose different purification methods were 
carried out. 
Immobilized-Metal Affinity Chromatography 
Nickel-nitriloacetic acid (Ni-NTA) agaroses are used for affinity binding to the polyhistidine 
tag. The recombinant protein with this fusion protein will bind to the immobilized nickel-
nitriloacetic acid on the agarose beads. The beads are then washed for unwanted substances, 
and eventually elution takes place for the purified recombinant protein. Because 6xHis tag has 
a pKa of 6.0, raised molar concentration of imidazole during elution will cause reduced pH and 
the histidine residue will be protonated. This causes the 6xHis tag to dissolve from the Ni-NTA 
beads65. For full length and His-tagged MK5: 
- 2 ml slurry of NI-NTA beads were equilibrated by centrifugation twice with 45ml 
ddH2O at 2,000g, 5 min, 4°C.  
- The water was then removed and beads retained.  
- The beads were then washed twice with 45 ml Lysis buffer A and centrifuged at 2,000 
x g, 5min at 4°C.  
- The supernatant was removed and the beads were mixed with the cell lysate for 2 hours 
on rotor (Analogue tube roller- SRT6) at 4°C.  
- The cell lysate was then centrifuged for 5 minutes at 2000 x g, 4°C and the supernatant 
was removed.  
- The beads with the bound proteins were then washed twice with Lysis buffer A, 
centrifuged for 5 min, 2000 x g at 4°C, and supernatant removed.  
- The beads were further washed with Lysis Buffer A + 25 mM imidazole, centrifuged at 
2000 x g, 5 min at 4°C, and the supernatant removed.  
- The slurry was then transferred to a gravity column in 4°C. For elution 20 ml of Elution 
buffer B was used and 9x1 ml elution fractions were taken with a gravity column for 
further evaluation by SDS-PAGE.  
- Protein concentration was measured using Nanodrop® ND-1000 spectrophotometer. 
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For MK5-His 372-473: 
- 4 ml slurry of NI-NTA beads were equilibrated by centrifugation twice with 45ml 
ddH2O at 2,000g, 5 min, 4°C.  
- The water was then removed and beads retained.  
- The beads were then washed once with 20 ml Buffer A and one more time with Buffer 
A + 5% imidazole 0,5 M 
-  Centrifuged at 2,000g for 5 minutes at 4°C.  
- The supernatant was removed and the beads were mixed with the cell lysate overnight 
on rotor (Analogue tube roller- SRT6) at 4°C.  
- The cell lysate was then centrifuged for 5 minutes at 2000 x g, 4°C and the supernatant 
was removed.  
- The beads with the bound proteins were then washed twice with Buffer A + β-
mercaptoethanol + protease inhibitor, centrifuged for 5 min, 2000 x g at 4°C, and 
supernatant removed.  
- The beads were further washed with Buffer A + β-mercaptoethanol + protease inhibitor 
+ 25 mM imidazole, centrifuged at 2000 x g, 5 min at 4°C, and the supernatant removed.  
- It was then eluted with Elution buffer B. 2 x 10 ml elutions were taken. The elutions 
were analyzed with SDS-PAGE. 
- Protein concentration was measured using Nanodrop® ND-1000 spectrophotometer. 
The glutathione S-transferase (GST) is a 26 kDa protein, whereas the His tag is 1 kDa. The 
elution condition is milder than of the His tag. GST binds to immobilized glutathione on the 
agarose beads, washed and eluted with excess of glutathione. Because the affinity to the 
glutathione in elution buffer is higher than of the beads, the GST-tag with the recombinant 
protein dissolves from the beads66. A batch purification was done in this study67. For GST-
tagged MK5 383-473 domain: 
- 5 ml slurry of Glutathione Sepharose® 4 Fast Flow was equilibrated by washing with 
20 ml dH2O, centrifuged at 4°C, 3000 RPM for 5 min. 
- The beads were then washed with 45 ml PBS solution, centrifuged at 4°C, 3000 RPM 
for 5 min. 
- The lysate was mixed with the beads and incubated with rotation for 30 min at 4°C. 
- Medium was sedimented by centrifugation at 500 x g, 4°C for 5 min, and the supernatant 
was discarded. 
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- The beads with the bound protein was then washed three times with 20 ml PBS solution. 
Centrifuged 500 RPM at 4°C for 5 min after each wash. 
- 3x5 ml elutions were taken by adding 50 mM Tris, 10 mM reduced glutathione and 
1:1000 β-mercaptoethanol, pH=8.0. 
- The proteins were analyzed with SDS-PAGE, aliquoted and stored at -20°C. 
Gel-Filtration Chromatography 
Gel-filtration chromatography separates proteins by the means of different molecular sizes. The 
gel matrices may differ in porosity, hydrophobicity and charge. Porosity leads to selection of 
smaller proteins, in which larger proteins may be excluded and swept through the column. 
Hydrophobicity and charge give chemical properties to the matrices where they can interact 
with the corresponding properties of the protein molecules. The matrix is packed in a 
chromatography column, sample mixture applied and an appropriate solution (mobile phase) is 
running through the column. The solution is eluted in decreasing order of size into fractions. 
An UV detector analyzes the samples68,69. 
 
Figure 9 Schematic presentation of the principle of gel-filtration chromatography. Bigger protein molecules that can not 
penetrate the porous matrix, are eluted first. The small proteins retain in the matrix is eluted later (adapted from 70). 
 
- Gel-filtration chromatography was done with following run parameters: 
Methods 
34 
 
Flow 1ml/min 
Pressure 0.5 MPa 
Elution length 1.5 CV 
Eluted fractions: 2ml 
 
Dialysis 
By dialysis, small molecular weight substances which are unwanted and may interfere 
subsequent assays are being eliminated. The sample proteins are placed in a semi-permeable 
membrane with a fixed pore size. Protein molecules which are bigger than that size, are being 
retained in the membrane. Smaller molecules and buffer salts pass through the membrane by 
means of passive diffusion, in which reduce their concentration in the sample. The membrane 
is embraced with a buffer solution, also called dialysate, which is usually 200-500 times the 
volume of the sample71. For MK5-His: 
- All the eluted fractions were collected together and were set to dialyze overnight at 4°C 
with 2L of the Dialysis buffer A. 4mg of recombinant TEV protease (Norstruct) was 
added to the buffer to cut off the His-tag on the MK5 proteins. 
- The collected elution was transferred to Snake Skin Dialysis tubing 3500 MWCO, 
which cut off molecules more than 3,5 kDa, lower size molecules will be able to pass 
through the membrane. His-tag is of 1 kDa and will pass through.  
- The membrane was then sealed and put in the buffer with stirring. 
- The solutions were aliquoted with glycerol and freezed at -20°C. 
For MK5-His 372-473: 
- The protein dialyzed in Dialysis buffer B with 4mg of recombinant TEV protease 
(Norstruct). 
- Snake Skin Dialysis tubing 3500 MWCO membrane was used. 
- The solutions were aliquoted with glycerol and freezed at -20°C. 
Concentration of the Protein 
Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-3 membrane was used for protein 
concentration. It has nominal molecular weight at 3 kDa, process volume of 15ml and is non-
sterile. With the nominal molecular weight of 3 kDa means molecules with 3 kDa and above 
will get filtrated out during centrifugation72. 
- Added up to 15ml of sample to the Amicon® Ultra filter device. 
- Centrifuged for 15 min at 4,000xg. 
Methods 
35 
 
- The concentrated solute was recovered with pipettor inserting into the bottom edge of 
the filter device. 
- The solutions were aliquoted with glycerol and freezed at -20°C. 
Mammalian Cell Culture Techniques 
Cell culture 
The A549 cells, which were derived from lung cancer cells from human, were cultured in 
Dulbecco’s Modified Eagle’s medium supplemented with 10% FBS and 1% penicillin-
streptomycin. Cell were incubated in Thermo-scientific nunc® EasyFlasks 175cm2 inside a 
HERAcell® 150i CO2 incubator at 37°C, 5% CO2 and 80-95% relative humidity. 
Cell splitting 
The cell culture was split 1-3 times a week, depending on cell confluence and planning of 
experiments. Before the splitting took place, medium and trypsin were warmed in 37°C heat 
incubator, PBS was kept at room temperature. 
- Old medium was discarded. 
- Washed Cells with 3-5ml PBS and removed. 
- Added 3ml 0.25% trypsin-EDTA and put in the heat incubator for few minutes for the 
trypsin to work. Made sure that the cells were not adherent to the surface by tapping the 
flask after heating. 
- 7ml medium with supplements were added and diluted 1:10. Fresh medium was filled 
up to 25ml. 
Counting Cells 
Bürker hemocytometer was used for cell counting. Cell counting is necessary prior to 
transfection for the calculation of 50-80% confluency of cells on the transfection day73,74. 
- The coverslip was affixed properly on the chamber. 
- After resuspension of cells with fresh medium, some cell culture was transferred under 
the affixed coverslip. 
- Cells were counted in at least 3 of the 9 A-squares under Zeiss AxioVert S100 inverted 
microscope. 
- Total cells/ml were obtained with the following formula:  
Cells
ml
=
Total cells counted x dilution factor x 104
number of squares
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Seeding of Cells 
After cell concentration estimation, approximately 500 cells/well were seeded in 60mm dishes. 
Cells were always seeded day before the planned transfection assay. The cells were seeded 
corresponding to “useful numbers for cell culture” by invitrogen™. 
- Total amount of cell suspension needed in mL was calculated with this formula: 
Cell suspension =
number of dishes x desired cell number in each dish
Cell concentration (
cells
ml
)
 
- The calculated cell suspension and 2 ml of medium were added to each dish. 
- The dishes were incubated overnight in the humidified incubator at 37°C and 5% CO2 
for further assay. 
Transfection 
Transfection is the introduction of genes into mammalian cells. The method can be used to 
check for gene expression on cell growth, genetic elements for regulation of expression, 
mutational analyses and to produce of specific protein73,75. There are various techniques for 
transfection. Calcium phosphate transfection and DEAE-dextran transfection attach the DNA 
on the cell surface before being endocytosed into the cells. Electroporation uses electrical field 
to open the pores of the cell so DNA can diffuse. The mechanism behind liposome-mediated 
transfection is not completely understood, negative charge of the phosphate group in DNA 
binds to the positively charged liposome. The positive surface of the liposome mediates the 
interaction between the DNA and the cell surface and the DNA enters the cell75. 
Transfection into A549 cells was done with Lipofectamine® LTX & PLUS™ Reagent76. 6-8 
60mm dishes were used each experiment. One dish was used for one transfection.  
- 1-3µg DNA was mixed with 500µl Opti-Mem® Medium and 1,5µl PLUS™ Reagent 
and incubated 5 min in room temperature. 
- 3 µl Lipofectamine® LTX Reagent was added to the mix and incubated for 30 min. 
- The whole content was transferred drop by drop into the dish with A549 cells. 
- Incubated overnight at 37°C in heat incubator. 
Harvesting 
The cells are usually harvested 24-72 hours after transfection77. 
- The medium from the 6mm dishes after transfection was discarded. 
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- Dishes were washed with 250µl PBS. 
- 200µl MAPKK lysis buffer + protease inhibitor was added to each dish. 
- The adherent cells were scraped off with a cell scraper. 
- Cells lysate was transferred to 1.5 ml pre-cooled microcentrifuge tube. 
- The tubes were put on ice for 15 min. 
- Tubes were then centrifuged for 10 min at 13.000 RPM in 4°C. 
- Supernatant was transferred to new tubes. 
- 39µl of sample was taken out for SDS-PAGE assay. 
- Lysate was stored in -70°C freezer with nitrogen pre-cooling first. 
Western Blot 
Western blot is a technique for separating and identifying proteins. The proteins are first 
separated by molecular weight by electrophoresis resulting in bands, which are transferred to a 
membrane. The membrane is then exposed for proper primary and secondary antibodies. 
Eventually, the antibodies bound to the bands can be visualize78. 
SDS-PAGE 
- SDS-PAGE was run with 2 standards: SeeBlue® Plus2 Pre-stained Protein Standard 
and MagicMark™ XP Western Protein Standard. 
Blotting 
-  Sponge pads, filter papers and membrane were prior soaked in 1x blotting buffer until 
saturation before use. 
- The pads, filter papers and membrane were assembled like a sandwich. Figure 10 
illustrates that. 
Methods 
38 
 
 
Figure 10 Blotting sandwich. The signals from the gel are transferred to the membrane (adapted from 79). 
- The blot was run at 25V for 1-2 hours. 
Blocking 
- After blotting was completed, the membrane was removed from blotting sandwich. 
- Membrane was soaked in 15 ml Odyssey® Blocking Buffer for 1 hour with gentle 
rocking. 
Antibodies Staining 
- 5 ml blocking buffer and 5 µl Tween 20 (1:1000 dilution) was mixed in new 50 ml tube 
by vortex.  
- Primary antibodies were the diluted in the solution and mixed. 
- Membrane was rolled with bands towards the inside in the new tube. 
- The membrane incubated overnight at 4°C on roller mixer. 
- Membrane was washed 4 x 5 minutes in TBS-T solution. 
- After washing, the membrane was incubated in 5 ml TBST-T solution with appropriate 
and diluted secondary antibody for 1 hour at 4°C. 
- Membrane was the once again washed with 4 x 5 minutes in TBST-T solution. 
- The membrane was analyzed with The Odyssey® Sa Infrared Imaging System. 
In Vitro Kinase Assay 
- Following were prepared on ice and incubated for 45 min at 30°C: 
Phosphorylated MK5 Unphosphorylated MK5 
5 µg MK5-HIS 5 µg MK5-HIS 
1 µl PET38 100 µM ATP 
100 µM ATP 5 µl 10x kinase buffer 
5 µl 10x kinase buffer X dH2O 
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X dH2O  
Total of 50 µl Total of 50 µl 
- 2x LDS sample buffer was added and heated for 10 min at 70°C. 
- The mixes were then diluted to 0,1 ng/µl, 1 ng/µl and 10 ng/µl. 
- 1x LDS sample buffer were added to the diluted solutions. 
- SDS-PAGE was then run. 
GST Pulldown Assays 
Pulldown assays are used to determine interaction between two proteins. The “bait” protein, 
which is tagged , can be an interacting protein for other proteins. With the bait protein bound 
to this other protein, they can be isolated by which the tag on the bait protein bind to 
immobilized affinity ligands80. 
- After transfection, the extract was thawed on ice. 
- 1µg GST and 1µg GST-MK5 382-473 was added to each extracts and incubated for 1 
hour at 4°C. 
- 10 µl washed Glutathion agarose (50% slurry) was added and incubated for further 30 
min at 4°C with rotation. 
- The samples were transferred to SigmaPrep™ spin column and washed 3 x 400µl MKK 
lysis buffer + protease inhibitor. 
- Eluted by adding 40µl 2x LDS sample buffer, heating at 70°C for 10 min, and spun out. 
- 20 µl of each sample was taken out for Western Blot assay with appropriate antibody. 
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RESULTS 
Generation of Vectors for Bacterial Protein Expression 
The aim was to insert the MK5 gene into a vector for protein expression in E. coli cells. For 
that the expression vector needs 1) a DNA sequence encoding a selectable marker that confers 
a trait for selection. This could be an antibiotic resistant gene, 2) a transcriptional promotor (e.g 
lac) that is controllable and when induced, can transcribe large amounts of mRNA from cloned 
gene for translation, 3) translational control sequences, such as a ribosomal-binding site (eg. 
Shine-Dalgarno, SD) and the start codone, ATG, for initiating expression, 4) a multiple cloning 
site for inserting the gene in a correct way in the vector81. MK5 protein should also have a 
fusion protein such as the His-tag, so that it could be purified later on. This can be achieved by 
inserting the MK5 gene into an expression vector. 
In addition to the expression vector, the DNA has to be introduced into an E. coli strain for 
protein expression. The BL21 (DE3) strain contains the rare codons encoding the amino acids 
arginine, isoleucine, and leucine that are rare in ordinary E. coli cells. It is also deficient in Ion 
and ompT protease, which degenerate the target protein in vivo61. The strain uses a T7 
polymerase system under the control of the lac promotor. Under conditions without IPTG, an 
inducer for protein expression, the lac promotor is repressed. Once IPTG is introduced, the 
repressor falls off and the T7 RNA polymerase can be expressed. When the T7 polymerase is 
expressed, it can bind to the T7 promotor on the expression vector and generate our gene of 
interest. The T7 RNA polymerase has many benefits such as: 1) faster RNA synthesizing than 
E. coli RNA polymerases, and less transcription terminating frequency, 2) selective for its 
initiation at its own promotor sequence, it does initiate for any other sequences in E. coli DNA, 
and 3) resistant to antibiotics that inhibit E. coli polymerases82. 
Construction of MK5 Expression Plasmid by Subcloning 
Experiments of cloning His-tagged MK5 with restriction enzyme digestion and ligation were 
conducted. Several clones were analyzed using the same restriction enzymes used in the 
cloning. One representative gel from a restriction enzyme analysis of 10 clones is shown in 
Figure 11. Cutting of a correct cloned expression vector should result in two fragments, one of 
1419 bp representing the MK5 gene and 5701 bp representing the pET-15b vector. The result 
depicted in Figure 11 show only one single fragment of around 5000 bp representing the empty 
vector from clone 1-2 and 4-10. In lane 3 we observe a major band at 3000 bp and two minor 
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bands at 6000 and above 7000 bp respectively. This represents uncut vector. We repeated these 
experiments several times with similar results. 
 
Figure 11: Restriction Digestion of MK5.  Purified plasmid DNA from 10 individual clones (1-10) digested with XhoI and 
NdeI, and run on a 1% agarose for 45 min at 90v. 1 Kb Plus DNA Ladder was used to visualize the molecular weight of linear 
double-stranded DNA fragments in UV-light. 
Construction of MK5 Expression Plasmid by “FastCloning” 
As we were unable to clone the His-tagged MK5 in a prokaryotic expression vector by standard 
restriction enzyme based cloning we need to use an alternative method. We choose to use the 
method called “FastCloning”. With “FastCloning”, the DNA insert and expression vector are 
PCR amplified before they are cut with the restriction enzyme DpnI and transformed into 
competent cells. Restriction with DpnI will cut methylated DNA sequences, reducing the 
background DNA templates. After PCR amplification of MK5 DNA insert and pCold II vector, 
the generation of PCR products were verified with agarose gel electrophoresis. Results depicted 
in Figure 12 shows that we were able to generate PCR fragments from the MK5 gene (1413 bp) 
and from the vector (4392 bp). 
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Figure 12: Post-PCR amplication of MK5 and pCold II. 1% agarose gel stained with ethidiume bromide and run for 45 min 
at 90v. Two samples of MK5 DNA (i1 & i2) and pCold II DNA (v1 & v2) were analyzed after PCR amplication. The gel shows 
MK5 with bands of 1413 bp and pCold II bands of 4392 bp. 1 Kb Plus DNA Ladder was used to visualize the molecular weight 
of linear double-stranded DNA fragments in UV-light. 
After DpnI digestion, the inserts and vectors were mixed 1:1, and transformed into Dhα cells. 
Plasmid DNA was isolated from 4 individual colonies and analyzed by restriction enzyme 
digestion with BamHI. Restriction enzyme analysis with BamHI should result in two separated 
fragments of 1413 and 4392 bp if the cloning was successful. As shown in the picture of the 
ethidium-bromide stained agarose-gel from this analysis, 3 of 4 clones were correct (Figure 13). 
 
Figure 13: Cut with BamHI. DNA from 4 colonies were cut prior to 1% agarose gel electrophoresis (run for 45 min at 90v). 
3 of the 4 lanes were successfully cut, which gave two bands, one at 1413 bp (MK5) and 4000 bp (pCold II). One lane had one 
band of 5000 bp. 1 Kb Plus DNA Ladder was used to visualize the molecular weight of linear double-stranded DNA fragments 
in UV-light. 
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Construction of Expression Plasmids for MK5 Domains  
We also wanted to express and purify the unique C-terminal domain of MK5. In order to do 
this we generated separate expression plasmid constructs with help of the “Gateway” 
recombination system as described in the methods sections. We cloned two different fragments 
representing amino acid 372-473 and 383-473 of MK5 respectively. These two domains of 
MK5 were cloned into two different vector, one with an N-terminal His-tag (pDEST17) and 
one with a N-terminal GST-tag (pDEST15) respectively. Subsequently, the purified DNAs 
from 8 individual colonies were cut with BsrGI before they were verified with 1% agarose gel 
electrophoresis. Successful cutting of GST-tagged MK5 domains should result in two 
fragments, around 400 and 5328 bp. For His-tagged MK5 domains, the two fragments are 
expected to be at around 350 and 4669 bp respectively. As depicted in Figure 14, all the clones 
were correct cut. 
 
Figure 14 MK5 fragments.Purified DNA from 8 individual colonies were cut with BsrGI prior to 1% agarose gel 
electrophoresis. Bands of around 6000 bp represent pDEST15 or pDEST17 vector. Bands of 400 represents the MK5 fragments. 
Analyzed with UV-light. 
Protein Expression 
Our goal was to express full-length MK5 and MK5 fragments for use in different assays. We 
wanted to produce large amounts of pure and soluble proteins in the shortest time as possible. 
The proteins should be in soluble form for easier purification with subsequently purification 
methods. Moreover, our aim was to gain structural information of the proteins. For that, the 
proteins should be refolded precisely to its native form in solutions. Purification with 
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denaturation and renaturation of the insoluble form of the protein do not assure correct 
refolding81.  
The solubility of proteins can be improved by changing expression conditions. These include 
the temperature, concentration of the inducer, media, sonication and OD600 prior to induction. 
Some fusion proteins enhance the solubility such as the maltose-binding protein (MBP), but in 
this study we used GST- and the His-tag. These tags do not enhance solubility61. We wanted to 
focus on OD600, temperature and sonication because these variables were critical for the proteins 
to be soluble. When the protein gels show significant and distinct bands of our protein generated 
via small-scale expression, large-scale expression can be proceeded. 
The optimization was carried out prior to the actual large scale protein expression and 
purification. This was to save time and resources in case the actual protein expression did not 
take place. When the protein gels show significant and distinct bands of the molecular weight 
of our protein of interest, we continued on with large scale expression. 
Optimization of MK5-His 
At first we wanted to conduct a small scale expression experiment of His-tagged MK5 to decide 
which conditions are best for protein expression. As shown in Figure 15 A, we did the first 
optimization experiment to set a reference. Right before induction, one sample 0 was taken. 
During induction with 1 mM isopropyl β-D-1-thiogalactopyranoside, one sample was harvested 
after 1,2,3,4, 5 hours and overnight. OD600 was at 0.650 prior to induction and temperature. 
during induction time was at 28°C.  
We wanted to test different OD600 and induction temperature. Higher OD600 and lower induction 
temperature were tested and this should result in stronger bands of 52 kDa (MK5-His) in the 
supernatant gel representing more soluble protein because of the lower temperature. As shown 
in Figure 15 B, this was true. The supernatant gel showed stronger bands of MK5-His in 
comparison to the background compared with condition A. Therefore, condition B was carried 
out for large scale protein expression. 
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Figure 15: Supernatant and pellet of MK5-His. SDS-PAGE run with MES running buffer. Bands of ~52 kDa revealed the 
MK5-His protein. A: Protein gels of supernatant and pellet before inducing with IPTG (0) and during 1mM IPTG induction 
after 1, 2, 3, 4, 5 hours and overnight (ov). The protein was harvested after overnight (ov) and analyzed as well. Induced at 
28°C during protein expression and sonicated 3 x 10s with Microson™ Ultrasonic Cell Disruptor. OD600=0.650 before 
induction. Stained with Coomassie Brilliant Blue. B: The protein was harvested with the same time interval as A), but temp. 
during protein expression the temp. was at 24°C and the protein sonicated for 5 min, 30 sec on and off with Bioruptor instead. 
OD600=0.860 before induction. 
Optimization of TEV 
Tobacco Etch Virus nuclear-inclusion-a endopeptidase (TEV) protease is used in cleaving off 
the His-tag. The TEV protease is a 27 Kda large catalytic domain from tobacco etch virus.  The 
native form of TEV cleaves itself so that it becomes truncated yielding diminished enzyme 
activity. Therefore, a more stable construct of TEV, the mutated TEVsh, was expressed in this 
study. The mutated form is more soluble and stable. The expression vector of TEVsh is pTH24, 
which is a derivate of the gateway vector pET-DEST42. It expresses a C-terminal V5 epitope 
and His-tag and the ampicillin resistance gene and the LacI gene. TEVsh protease is 33 kDa 
due to its extra amino acids sequences from the vector83. 
We carried out a total of six optimization experiments for the His-tagged TEVsh. We wanted 
to test different OD600 prior to induction and induction temperature to see what the best 
condition is. One sample, 0, was taken before induction with 1 mM IPTG. The samples were 
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also harvested after 1, 2, 3, 4, 5 hours and overnight and centrifuged the next day to separate 
the supernatant and pellet. The supernatant and pellet samples were analyzed with run with 
SDS-PAGE and analyzed as shown in Figure 16 and Figure 17. 
Figure 16 shows three experiments conducted with OD600=1.350, 0.573 and 0.992 under the 
induction temperature of 37°C. Samples taken overnight (ov) for supernatant in 37°C did not 
show bands of TEV, while after 1 hour of induction we could already see the TEV of 33 kDa 
was expressed for experiments A-C. Gel B (supernatant) seems to have the strongest and purest 
band after 2 hours of induction with OD600=0.573 out of the three supernatant gels. 
 
Figure 16: Supernatant and pellet of TEV, induced at 37°C. Three optimization experiments, A), B) and C), of TEV protease 
under the induction temperature of 37°C and run on SDS-PAGE with MES running buffer. Lane 0 indicates before IPTG 
induction. Samples were harvested after 1, 2, 3, 4, 5 hours and after overnight (ov). Sonicated for 5 min, 30 sec on and off with 
Bioruptor. The 33 kDa bands revealed the TEV protein. Stained with Coomassie Brilliant Blue. A: OD600=1.350 prior to 
induction. B: OD600=0.573. C: OD600=0.992. 
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We also tested with induction temperature at 24°C of OD600=1,280, 0.865 and 0.473 as depicted 
in Figure 17. Total lysate, t0 and t1, were also taken, before induction and after overnight, 
respectively. Total lysates are solutions before separation to supernatant and pellet. The total 
lysates before induction should result in no distinct band of 33 kDa representing TEV. Visible 
bands of TEV could first be seen after 2 hours of induction for all experiments depicted in 
Figure 17 D-F. Out of all the experiments, A-F, experiment B (Figure 16) with OD600=0.573 
and induction temperature at 37°C, seems to yield the strongest distinct band from the 
background after 2 hours of induction. We did not proceed with large-scale expression and 
purification of TEV, because we got some stored TEV protease left for using in the purification 
step of His-tagged MK4 and its segments. For the TEV protease protocol for expression and 
purification, please refer to Carlsen et al.’s protocol83. 
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Figure 17 Supernatant and pellet of TEV, induced at 24°C. Samples were harvested before induction (0) and after 1, 2, 3, 
4, 5 hours and after overnight (ov). tl0=total lysate (both supernatant and pellet) before induction, tl1=total lysate after 
overnight. SDS-PAGE with MES running buffer. Sonicated for 5 min, 30 sec on and off with Bioruptor. Bands of 33 kDa 
revealed the TEV protein. Stained with Coomassie Brilliant Blue. D: OD600=1.280 prior to induction. E: OD600=0.865. F: 
OD600=0.473. 
Optimization of MK5 Segments 
The MK5 segments of 372-473 and 383-473 are of important. In order for expression of these 
proteins, a new series of optimization experiments were carried out. Since each protein has its 
own biophysical characteristics, it is often required to change the expression protocol to yield 
successful soluble proteins. Therefore, different OD600 and temperature were tested with the 
MK5 fragments. We used temperature of 37°C to start off with, because this would give shorter 
induction time before proteins are expressed.  
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MK5-His fragments 
The His-tagged amino acids 383-473 and 372-473 of MK5 were tested with induction 
temperature of 37° as shown in Figure 18. We expected to get bands of 15 kDa representing 
our protein. A before induction sample (0) was taken. After induction with 1 mM IPTG, samples 
were taken after 1.75, 4.258 hours and overnight (ov) for the 383-473 domain. Samples were 
taken after 2.5, 5 hours and overnight (ov) for the 372-473 domain. The supernatant gel of 
experiment B showed major bands of 15 kDa than in experiment A. Moreover, there are bigger 
15 kDa bands in the pellet gels than in the supernatants. 
 
Figure 18: MK5-His 383-473 and MK5-His 372-473. SDS-PAGE with MES running buffer of MK5-His fragments A and B 
for both pellet and supernatant. The separation to pellet and supernatant was due to centrifugation of the samples taken after 
the specified time (A: 0, 1.75, 4.25 hours and overnight. B: 0, 2.5, 5 hours and overnight). Induced at 37°C and sonicated 3 x 
10 sec (Microson™ Ultrasonic Cell Disruptor). 0=prior to 1 mM IPTG induction. Bands of ~14-15 kDa reveal the MK5-His 
fragments. Stained with Coomassie Brilliant Blue. A: OD600=0.710. Samples were harvested and run on gel after 1.75, 4.2 
hours and overnight (ov). B: OD600=0.872. Harvested after 2.5, 5 hours and overnight (ov). 
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MK5-His 372-473 
As the supernatant gel for MK5-His 372-473 showed strongest bands out of the two 
experiments of MK5-His domains (372-473 and 382-473), we chose the His-tagged MK5 372-
473 to proceed with. We changed the induction temperature to 24°C, increased the OD600 to 
1.640 and extended the sonication (6 x 10 sec). The extended sonication was due to the stronger 
bands in the pellet gel than in the supernatant (Figure 18). We expected not to get any strong 
bands at around 15 kDa representing the MK5-His 372-473, because the OD600 was much 
higher than the mid-log phase (OD600 of ~0.6 to 0.9). The mid-log phase is when bacterial cells 
is growing exponentially, this assures new and fresh cells for expression. As depicted in Figure 
19 A, the results were true, the bands representing the domain were weak. 
We wanted to do the experiment of the His-tagged 372-473 domain again, but this time with 
lower OD600. Two experiments were conducted with induction temperatures 24°C and 37°C, 
respectively. Lower OD600 should result in stronger bands of ~15 kDa. It was as expected as 
shown in Figure 19 B and C. The supernatant gel in B showed strongest bands out of the three 
gels. Condition B was therefore proceeded for large scale expression. 
 
Figure 19: MK5-His 372-473 fragments. SDS-PAGE with MES running buffer of MK5-His fragments in various conditions. 
0=prior to 1 mM IPTG induction. The protein was harvested after 3 and 5 hours and overnight (ov). The samples were sonicated 
6 x 10 sec (Microson™ Ultrasonic Cell Disruptor) prior to separation to pellet and supernatant with centrifugation, and run on 
SDS-PAGE. Bands of ~15 kDa indicate the MK5-His 372-473. Stained with Coomassie Brilliant Blue. A: OD600=1.640 prior 
to induction. Induction temp.=24°C. B: OD600=0.664. Induction temp.: 24°C. C: OD600=0.644. Induction temp.: 37°C. 
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MK5-GST fragments 
We wanted to proceed with MK domains that are GST-tagged too, so one experiment of amino 
acids 372-473 and 382-473 were carried out. The induction temperature was set to 37°C. The 
protein gels should result in bands of 39 kDa representing the MK5 domains. As shown in 
Figure 20, this was true. The supernatant gel in B showed strongest bands of 39 kDa after 3 and 
5 hours. Therefore, condition B was proceeded for large scale expression. 
 
Figure 20 MK5-GST fragments. Protein gel of MK5-GST 372-473 (A) and MK5-GST 383-473 (B) of both pellet and 
supernatant. Samples were taken prior to 1 mM IPTG induction (0), after 3, 5 hours and overnight, and separated to pellet and 
supernatant with centrifugation. The samples were then analyzed with SDS-PAGE with MES running buffer. Bands of ~39 
kDa indicate the MK5-GST fragments. Sonicated 6 x 10 sec (Microson™ Ultrasonic Cell Disruptor). Induction temp.: 37°C. 
Stained with Coomassie Brilliant Blue. A: OD600=0.804. B: OD600=0.960. 
Protein Purification 
We wanted our proteins as pure as possible. Therefore, many purification techniques were 
carried out.  
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IMAC of MK5-His 
The goal for the method immobilized affinity chromatography is to bind the 6 consequently 
histidine that are coupled with MK5 to NiNTA agarose beads as described in the methods 
section. The bound protein was then washed with with Lysis buffer A and 25 mM imidazole. 
The lysis buffer contains appropriate salts at pH=8, lysozyme for breaking down bacterial cell 
walls, β-mercaptoethanol for reducing disulfide bonds between proteins and protease inhibitor 
for reduction of the degeneration of protein. The bound protein was then eluted with Elution 
buffer B. In this way, our protein becomes isolated from impurities. 9 eluates were taken, with 
the 1st eluate from left to the 9th eluate to the right as depicted in Figure 21. If the purification 
was successful, the SDS-PAGE gel after elution would result in bands of 52 kDa representing 
MK5-His. Moreover, the background bands should be of lesser because of the washing step. 
The gel shows that was true. Eluates 1 and 3-9 show little background and lane 2 show strongest 
band representing MK5. Since the eluates were generally pure and all lanes contained our 
protein, they were collected together with 6 more eluates of the protein. The last 6 eluates were 
not analyzed with SDS-PAGE. 
 
Figure 21 SDS-PAGE of 9 eluates of MK5-His after IMAC. 9 eluates separated on SDS-PAGE run with MES running 
buffer. Stained with Coomassie Brilliant Blue. Bands of ~52 kDa indicate the MK5-His protein. Lane 1 with the first eluate, 
lane 2 with the second eluate and so on of totally 9 eluates. Eluate 2 shows biggest band representing the His-tagged MK5. The 
protein solution was harvested after 5 hours of 1 mM IPTG induction with induction temp. of 24°. 
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Gel-Filtration Chromatography of MK5-His 
With gel-filtration chromatography, we wanted to isolate the collected MK5-His eluates. Gel-
filtration chromatography separates the protein molecules by size with the biggest size being 
eluted out first. Gel-filtration chromatography has many advantages. It can be tailored to your 
study of interest; matrix, column and buffer can be varied leading to different resolutions on 
the chromatogram. The stationary phase is inert, which will not react with the samples. It has 
some disadvantages too. When the compression of the bed is not properly set, it can decrease 
the flow rate, air bubble in the column and tailing arises. Tailing is when a peak is leaving a tail 
on the chromatogram69. Eluates were collected in 2 ml tubes. 
We expected to have a peak for void volume, where protein molecules bigger than 600 kDa are 
excluded from the column, i.e. not passing through the pores in the matrix. The highest peak 
representing the His-tagged Mk5 and a peak at 33 kDa are also expected. During optimization 
step, we investigated that two strong bands at 52 and 33 kDa on the supernatant gel after 5 hours 
of induction (Figure 15 B). Figure 22 shows the void volume, the highest peak in eluate D9 and 
two overlapping minor peaks right to the highest one. 
 
Figure 22 Gel-filtration  of MK5-His. Gel-filtration chromatogram of MK5-His. X-axis: mAU (milli absorbance units) at 
OD280. Y-axis: Elution volume (ml). Exclusion limit=600 kDa. After IMAC purification, the eluates were collected and run on 
gel-filtration chromatography. Analyzed on UV with OD280. 
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As the gel-filtration chromatogram only showed the separation of different protein molecules 
by weight, we wanted to investigate what molecular weight the different peaks represent. In 
order to do that, SDS-PAGE was done for eluates C10, C12, D12, D11, D9, D8, D7, D6, D5,, 
D4, D2 and D1 as shown in Figure 23. The eluates D9, D6 and D1 should result in three distinct 
bands of different weights respectively. This was correct, D9 shows strongest band of 52 kDa 
representing MK5-His, D6 has two strong bands of 52 and 33 kDa, D1 show a band of 6 kDa. 
Therefore, these molecular weights represent the 3 overlapping peaks in the chromatogram 
(Figure 22). Eluates D11-7 contained our protein, so they were collected together for dialyses 
and concentration steps as described in the methods section. 
 
Figure 23 SDS-PAGE of gel-filtration eluates. 11 eluates from the gel-filtration chromatography were 
verified on SDS-PAGE stained with Coomassie Brilliant Blue. Eluate D9 shows strongest band 
of MK5-His. 
IMAC of MK5-His 372-473 
The goal for this experiment was to isolate and purify the His-tagged MK5 with the domain 
372-473. The His-tagged MK5 372-473 was washed with Buffer A + 1:1000 β-mercaptoethanol 
+ protease inhibitor + 25 mM imidazole instead of the Lysis buffer A, and eluted with Elution 
buffer B. The washing buffer used in this purification step did not contain lysozyme, which 
breaks down the cell walls of bacterial cell to yield more soluble proteins. As seen in the 
optimization step for MK5-His 372-472 (Figure 19 B), the supernatant gel showed strong and 
distinct bands representing the MK5 domain. Therefore, it was not necessary to include the 
lysozyme in the washing buffer. 2 x 10 ml eluates were taken and analyzed with SDS-PAGE. 
The gel should result in bands of 15 kDa representing our protein. This was true as depicted in 
Figure 24. Eluates 1 and 2 show our protein of around 15 kDa The eluates were therefore 
collected together for dialysis and storage as described in the methods section. 
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Figure 24 Eluates of MK5-His 372-473. SDS-PAGE of 2 eluates after IMAC, stained with Coomassie Brilliant Blue. Eluate 
1 has stronger band of 15 kDa representing MK5-His 372-473 than in eluate 2. Induced at 24°C with 1mM IPTG and harvested 
after 3 hours prior to SDS-PAGE analysis. 
IMAC of MK5-GST 383-473 
We wanted purify and isolate the GST-tagged MK5 383-473 fragment. The GST-tag is a 26 
kDa fusion protein, while the His-tag is of 1 kDa. The GST-tag is easily detected in enzyme 
assay and immunoassay. It has mild elution condition, minimizing the risk of degenerating the 
recombinant protein and because of its size, it will form dimers. The His-tag is only easily 
detected on immunoassays. Its elution condition is not mild as for GSTs, imidazole may cause 
precipitation. His-tag is small and will less likely interfere with the structure and function of 
the recombinant protein66.  
In order to purify the GST-tagged MK5 383.473, the protein was first bound two glutathione 
agarose beads and washed with PBS solution. 3x5 ml eluates were then taken by adding 50 mM 
Tris, 10 mM reduced glutathione and 1:1000 β-mercaptoethanol, pH=8.0. The proteins were 
then analyzed with SDS-PAGE. The protein gel should result in bands of 39 kDa representing 
MK5-GST 383-473. Figure 25 shows 3 eluates having the bands of 39 kDa. Thus, all the eluates 
consisted of our protein. They were then collected together and aliquoted.  
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Figure 25 Eluates of MK5-GST 383-473 after IMAC. Three Eluates of MK5-GST 383-473 with bands of 39 kDa were 
revealed on SDS-PAGE stained with Coomassie Brilliant Blue. Induced with 1 mM under the temp. of 37°C and harvested 
after 5 hours. 
Protein-protein Interactions Studies 
In order for testing interactions between MK5 and its fragments with ERK4, the ERK4 protein 
have to be generated. It is generated by introducing the gene, encoding the ERK4 in a eukaryotic 
expression vector, into mammalian cells. The eukaryotic expression vectors should at least 
contain; 1) eukaryotic transcription regulatory elements such enhancer and promoter, 2) 
prokaryotic replication origin, for replicating in E. coli and 3) prokaryotic selective marker84. 
Overexpression of ERK4 Protein 
The goal was to express proteins in eukaryotic cells. By mammalian expression the recombinant 
proteins expressed are usually properly modified where their structure is generated correctly 
and their activity is fully mained85,86.  
We wanted to produce cell extracts with overexpression of ERK4 proteins, both wild-type and 
several mutants. In order to do this, eukaryotic expression plasmids encoding myc-tagged 
ERK4 (wt), myc-tagged ERK4 where the serine 186 in the activation-loop is changed to the 
unphosphorylable alanine (ERK4 S186A) or FLAG-tagged ERK4 were transfected into A459 
mammalian cells and lysates were harvested for Western-Blot assay. The membrane was 
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probed with anti-ERK4 primary antibodies and anti-sheep thereafter. Anti-sheep secondary 
antibodies were used for visualization. We expected the ERK4 proteins to be around 70 kDa. 
As shown in Figure 26, the results from the ERK4 antibody revealed us that we succeeded in 
transfection of myc-tagged ERK4 and S186A. Bands of ERK4-FLAG were weaker than the 
two other ERK4 protein variants. Myc-tagged ERK4 and ERK4-S186A were used as cell 
extracts in the GST-pulldown assay. 
 
Figure 26 Western-blot of ERK4. Membrane of 2 samples of negative control (Neg.) myc-tagged ERK4 (wt), myc-tagged 
ERK4-S186A and FLAG-tagged ERK4. The analysis revealed bands of 70 kDa representing ERK4 (wt), myc-tagged ERK4-
S186a and FLAG-tagged ERK4. Bands of ~38 is also revealed. Probed with primary antibody: anti-ERK4 and secondary 
antibody: anti-mouse (IR 700).  
GST-pulldown of ERK4 
MK5 acts as a substrate for ERK4. In this experiment we wanted to test if myc-tagged ERK4 
protein generated from A549 cells could interact with GST-MK5 383-473. In order to achieve 
this, extracts containing myc-tagged ERK4 (wt) and ERK4 S186A were incubated with the  
GST-tagged MK5 383-473, and with the help of glutathione-agarose we isolated the GST-MK5 
together with ERK4. After GST-pulldown assay as described in the methods section, the 
samples underwent western-blot and probed first with anti-ERK4 and subsequently with anti-
GST to verify if the fusion protein GST was present in the pulldowns. Successful pulldown of 
ERK4 proteins should result in bands of 70 kDa representing the ERK4 proteins in lanes 
representing the MK5-GST 383-473 and the ERK4 proteins. In the control lanes (GST + ERK4 
proteins), no bands of 70 kDa should be present. As depicted in Figure 27 A, a weak band of 
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around 62 kDa may indicate the pulled down of ERK4 S186A by the means of MK5-GST 383-
473. When re-probing with anti-GST, we should get bands of 26 kDa representing the GST 
protein for the GST + ERK4 control, and bands of 39 kDa representing the GST-tagged MK5 
383-473. Figure 27 B shows 3 bands of 26, 38 and 80 k Da for the GST protein incubated with 
the ERK4 proteins (GST + ERK4 and GST + ERK4 S186A). For MK5-GST 383-473 + ERK4 
proteins, 3 bands of 16, 27 and 51 kDa were reaveled. The ones at 16 kDa being weaker than 
other two bands. As expected in the GST + ERK4 controls, GST bands of 26 were present. 
However, the other two bands may implicate impurities. For MK5-GST + ERK4 proteins, the 
band of 39 kDa representing the GST-tagged Mk5 383-473 did not appear as expected, but 
instead three other bands, which could represent impurities, were present. 
 
Figure 27 GST-pulldown of ERK4.Western-Blot after GST-pulldown of the myc-tagged ERK4 (wt) and myc-tagged ERK4 
S186A by the means of MK5-GST 383-473. GST protein + ERK 4 proteins serve as a control. A: Probed first with the primary 
antibody anti-ERK4. Visualized by probing with the secondary antibody anti-sheep under IR700. A band of ~70 kDa may 
indicate ERK4. B: Reprobed with anti-GST and anti-rabbit IR800. 
Co-Transfection 
In this study we wanted to test if myc-tagged ERK4 co-expressed with GST-MK5 or GST-MK5 
372-473 in the lysate of A549 cells could interact with each other. In order to achieve this, 
expression vectors encoding myc-tagged ERK4 (wt) and ERK4 S186A were co-transfected 
with expression vectors encoding GST-tagged fusion protein with the full length MK5 or the 
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amino acid 383-473 of MK5, and with the help of glutathione-agarose isolate the GST-MK5 
proteins together with ERK4 proteins. After transfection and the cell lysates were harvested, 
they were analyzed on Western-blot and probed first with anti-GST to verify the presents of 
GST fusion proteins bound to MK5 and MK5 372-473. This would result in bands of 80 and 
40 kDa, representing MK5-GST and MK5-GST 372-483 respectively if the transfection was 
successful. Shown in the left picture in Figure 28, are the bands for MK5-GST and MK5-GST 
372-483, which means successful transfection of MK5 proteins.  
To test if the ERK4 proteins were successfully transfected, the membrane was reprobed with 
anti-ERK4 and it should result in bands of 70 kDa representing the ERK4 protein where the 
ERK4 proteins are presented. As depicted in the right picture in Figure 28, 4 last lanes 
representing the GST-MK5 and ERK4 proteins showed positive results. 
 
Figure 28 Pre-GST pulldown assay. Western-Blot gel after co-transfection of MK5 + ERK4, MK5 + ERK 4 S186A, MK5 
372-473 + ERK4 and MK5 372-473 + ERK4 S186A. Negative control (Neg.) lane has none of the MK5 or ERK proteins 
transfected. Probed with anti-GST (left) and anti-rabbit IR800. Reprobed with anti-ERK4 and anti-sheep IR700. 
As it was shown successful transfection of MK5 and ERK4 proteins, the samples were bound 
to glutathione agarose, washed and eluted as described in the GST-pulldown assay method 
section. The eluates were analyzed with Western-blot probing with anti-ERK4 first. This should 
result in bands of 70 kDa representing ERK4 except for the lane containing just MK5-GST. 
The left picture in Figure 29 shows that it was correct, the 4 last lanes containing the ERK4 
proteins had bands of 70 kDA. In order to check if the GST-tagged MK5 proteins were 
successfully pulled down with glutathione and to verify that ERK4 proteins were bound to the 
GST-MK5s, the membrane was reprobed with anti-GST. Bands of 80 and 40 kDa representing 
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the MK5-GST and MK5-GST 372-483 respectively, were present in the right picture in Figure 
29. This shows that the ERK 4 proteins bind to MK5 proteins during GST-pulldown assay. 
 
Figure 29 Post-GST pulldown. Membrane probed with anti-ERK4 (anti-sheep IR700) and reprobed with anti-GST antibodies 
(anti-rabbit IR800). MK5-GST and MK5-GST 372-473 co-transfected with ERK4 (wt) and its mutation, ERK4 S186A. MK5-
GST serves as a control. MK5-GST + ERK4 in the left picture has the weakest band of the 4 bands. In the right picture, the 
same lane showed in addition to a weak band of MK5-GST, a weak band of 50 kDa. 
Protein Kinase Activity Assays 
MK5 
We wanted to test if 3 different MK5 antibodies bind to the phosphorylated His-tagged MK5 
of 3 different concentrations (0.1, 1 and 10 ng/µl). The MK5 antibodies only bind to the 
phosphorylated amino acid threonine 182 in the activation loop of MK5 proteins. The 
antibodies to be tested were anti-MK5 P-T182 (3. Bleed 0.21 mg/ml), anti-MK5 P-T182 (1. 
Bleed 0.12 mg/ml) and anti-MK5 P-T182 (3. Bleed 0.13 mg/ml). In order to do this, the in vitro 
kinase assay was carried out as described in the methods section. The Western-blot membrane 
should result in bands of 52 kDa representing the His-tagged MK5 protein if antibodies were 
able to bind. The 10 ng/µl lane should yield the strongest band because of higher MK5-His 
concentration. As shown in Figure 30, both anti-MK5 P-T182 (3. Bleed 0.21 mg/ml) and anti-
MK5 P-T182 (3. Bleed 0.13 mg/ml) were able to bind to the phosphorylated amino acid 
threonine 182 in the activation loop of MK5. Moreover, the testing with anti-MK5 P-T182 (3. 
Bleed 0.21 mg/ml) yielded the strongest band in lane 10 ng/µl. 
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Figure 30 Different primary antibodies for phosphorylated MK5-His. Probed with 1:1000 dilution of anti-MK5 P-T182 
(3. Bleed 0.21 mg/ml), anti-MK5 P-T182 (1. Bleed 0.12 mg/ml) and anti-MK5 P-T182 (3. Bleed 0.13 mg/ml) (anti-sheep 
IR700). 3 lanes of dilutions of MK5-His, 0.1, 1 and 10 ng/µl. Strongest bands of MK5-His appeared with anti-MK5 P-T182 
(3. Bleed 0.21 mg/ml). In addition to this one band, bands of 20 kDa were revealed in membranes probed with anti-MK5 P-
T182 (3. Bleed 0.21 mg/ml) and anti-MK5 P-T182 (3. Bleed 0.13 mg/ml). 
As the anti-MK5 P-T182 (3. Bleed 0.21 mg/ml) gave strongest bands in 1:1000 solution, we 
wanted to investigate again this time in 1:200, 1:500 and 1:1000 dilution of anti-MK5 P-T182 
(3. Bleed 0.21 mg/ml). In order to do this, three new membranes with the same concentration 
of MK5-His (0.1, 1 and 10 ng/µl) were probed with different anti-MK5 P-T182 (3. Bleed 0.21 
mg/ml) concentrations. It was to get the strongest band of 52 kDa representing the MK-His in 
lane 10 ng/µl when probed with anti-MK5 P-T182 (3. Bleed 0.21 mg/ml) in 1:200 dilutions. 
This was true as shown in Figure 31. All three membrane showed bands of 20 kDa as well. The 
bands of MK5-His in the 1:200 and 1:500 dilutions were similar, so we proceeded with the 
1:500 dilutions of anti-MK5 P-T182 (3. Bleed 0.21 mg/ml). 
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Figure 31 MK5-His with different anti-MK5 P-T182 (3. Bleed 0.21 mg/ml) concentrations. Membranes of phosphorylated 
MK5 in 3 different concentrations (0.1, 1 and 10 ng/µl) were probed with anti-MK5 P-T182 (3. Bleed 0.21 mg/ml) (in 1:200, 
1:500 and 1:1000 dilutions). Visualize with anti-sheep IR700. Bands of 52 and 20 kDa were detected. 
We wanted to verify if the phosphorylated membranes were properly phosphorylated. In order 
to do this, a membrane of unphosphorylated MK5-His was probed with anti-MK5 P-T182 (3. 
Bleed 0.21 mg/ml) in 1:500 dilutions. This should not result in bands of 52 kDA representing 
the unphosphorylated His-tagged MK5. Figure 32 shows that it was true. The anti-MK5 P-T182 
(3. Bleed 0.21 mg/ml) antibody only visualize phosphorylated MK5-His. 
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Figure 32 Nonphosphorylated MK5-His with anti-PRAK antibody. Unphosphorylated membrane of MK5-His in three 
concentrations (0.1, 1 and 10 ng/µl) probed with 1:500 anti-PRAK (anti-sheep IR700). A band of 20 kDa was shown in the last 
lane. 
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DISCUSSION 
The electrophoresis of the 10 clones resulted in a lane with a major band at 3000 bp and two 
minor bands at 6000 and above 7000 bp respectively. This raised our concern what this would 
be. Looking at the MK5 DNA insert and the pET-15b expression vector, they contain 1419 bp 
and 5708 bp respectively. Cut with NdeI and XhoI of MK5 DNA would give many 1419 bp 
DNA fragments with compatible sticky ends. During ligation, two of them could have bound 
to each other through compatible ends where NdeI or XhoI cuts, yielding the 2838 bp long 
fragment representing 2 MK5 DNA inserts. Consistently, this could successful cut of the MK5 
DNA inserts and not the cut of vector. Moreover, with this basic idea more than 2 of the MK5 
DNA insert could bind each other, yielding the 4257 bp, 5676 bp and 7095 bp for 3, 4 and 5 
DNA inserts bound together respectively. Thus, the 6000 bp and 7000 bp band could indicate 
the 4 and 5 ligated MK5 inserts. However, one can question why the vector was not cut and 
ligated with the MK5 insert instead. This possibility could be ruled out because the vector was 
uncut. Furthermore, why 3 insert strands did not ligate each other remain questionable. 
From optimization of protein expressions show that extended sonication, lower induction 
temperature and OD600 in mid-log phase yield good amount of soluble proteins. However, the 
pellet gels representing our proteins in inclusion bodies indicate much more of proteins that 
could be soluble. According to Francis et al.’s Strategies to Optimize Protein Expression in 
E.coli61, reducing the temperature would give a slower transcription and translation rate, thus 
reducing the aggregation of the proteins in inclusion bodies. We carried out the expression at 
24°C at the lowest, and therefore, lowering the induction temperature may give more soluble 
proteins. However, longer induction time is required then. Another parameter is the IPTG that 
we used 1 mM of in all our expression experiments. Lowering this inducer will give slower 
transcription rate resulting in more soluble proteins. Hence, it is possible to get more soluble 
proteins by changing these parameters. 
It is known that MK5 interacts with ERK3/4 through the phosphorylation-dependent FRIEDE-
motif located C-terminal to the common docking domain sequence in ERK3/435. The sequence 
that the MK5 protein interacts ERK3/4 with is in the C-terminal and it is of 100 amino acids36. 
The results from the GST-pulldown after co-expression of amino acid 372-473 of MK5 and 
ERK4 showed binding of the segment to ERK. According to Aberg et al., they describe a 383-
473 residues of MK5 in the C-terminal binds to the FRIEDE site when co-transfected into HeLa 
cells. Consistently, the result picture shows that the 372-473 C-terminal motif of MK5 binds to 
ERK3/4. The amino acid 383-473 of MK5, which is 12 amino acids shorter in the C-terminal 
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of FRIEDE motif, indicate that the binding site required to interact with ERK3/4 is of shorter 
sequence.  
Another finding of ours, is that the 383-473 residues of MK5 protein bind to ERK4 where the 
phosphor-acceptor serine 186 is replaced with alanine, in vitro with GST-pulldown. This was 
in consistent with the fact that MK5 is partially phosphorylated and thus activated by this 
mutant87. However, the same binding to ERK4 wildtype did not occur despite that MK5 is fully 
bound and activated by ERK3/4 when the phospho-acceptor sites in the activation loop are 
phosphorylated in vivo and in vitro. 
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CONCLUSION 
- Mid-log OD600, lower induction temperature and extended sonication time are important 
for expression of soluble proteins. 
- Amino acid domain 372-473 binds to ERK4. 
Future Perspectives 
- The found protein expression conditions for TEV, MK5 and its fragments can be used 
in future studies to save time spending on optimization of protein expression in E. coli. 
- More work is required to carry out the crystallization of MK5. 
  
References 
67 
 
REFERENCES 
1. WHO | Cancer. [accessed 2016 Mar 8]. http://www.who.int/mediacentre/factsheets/fs297/en/ 
2. Cancer in Norway 2014 - Kreftregisteret. [accessed 2016 Apr 25]. 
http://www.kreftregisteret.no/en/General/Publications/Cancer-in-Norway/Cancer-in-Norway-
2014/ 
3. Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. 2011;144(5):646–
674. 
4. What Is Cancer? - National Cancer Institute. [accessed 2016 Mar 9]. 
http://www.cancer.gov/about-cancer/what-is-cancer 
5. Proto-oncogenes to Oncogenes to Cancer | Learn Science at Scitable. [accessed 2016 Mar 9]. 
http://www.nature.com/scitable/topicpage/proto-oncogenes-to-oncogenes-to-cancer-883 
6. Types of Cancer Treatment - National Cancer Institute. [accessed 2016 Mar 9]. 
http://www.cancer.gov/about-cancer/treatment/types 
7. Fabbro D. 25 years of small molecular weight kinase inhibitors: potentials and limitations. 
Molecular Pharmacology. 2015;87(5):766–775. 
8. Signal-Transduction Pathways: An Introduction to Information Metabolism - Biochemistry 
- NCBI Bookshelf. [accessed 2016 Apr 25]. http://www.ncbi.nlm.nih.gov/books/NBK21205/ 
9. Enzyme-linked Receptors. Tocris Bioscience. [accessed 2016 Apr 25]. 
https://www.tocris.com/pharmacologicalBrowser.php?ItemId=187854 
10. Signal Transduction. Tocris Bioscience. [accessed 2016 May 5]. 
https://www.tocris.com/pharmacologicalBrowser.php?ItemId=187888 
11. Nuclear Receptors | Tocris Bioscience. [accessed 2016 May 12]. 
https://www.tocris.com/pharmacologicalBrowser.php?ItemId=151484#.VzRHaFWLTIU 
12. kinase | enzyme | Britannica.com. [accessed 2016 Mar 10]. 
http://global.britannica.com/science/kinase 
13. Hanks SK, Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase 
(catalytic) domain structure and classification. The FASEB Journal. 1995;9(8):576–596. 
14. Wang Z, Cole PA. Catalytic Mechanisms and Regulation of Protein Kinases. Elsevier Inc. 
548:1–21. 
15. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The Protein Kinase 
Complement of the Human Genome. Science. 2002;298(5600):1912–34. 
16. Protein Kinases: Introduction | CST. [accessed 2016 Mar 16]. 
http://www.cellsignal.com/common/content/content.jsp?id=kinases 
17. Berg JM, Tymoczko JL, Stryer L. Enzymes Can Be Inhibited by Specific Molecules. 2002 
[accessed 2016 May 5]. http://www.ncbi.nlm.nih.gov/books/NBK22530/ 
References 
68 
 
18. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-Activated Protein Kinase: 
Conservation of a Three-Kinase Module From Yeast to Human. Physiological Reviews. 
1999;79(1):143–180. 
19. Coulombe P, Meloche S. Atypical mitogen-activated protein kinases: Structure, regulation 
and functions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 
2007;1773(8):1376–1387. (Mitogen-Activated Protein Kinases: New Insights on Regulation, 
Function and Role in Human Disease). 
20. Pearson G, Robinson F, Beers Gibson T, Xu B, Karandikar M, Berman K, Cobb MH. 
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions. 
Endocrine Reviews. 2001;22(2):153–183. 
21. Cargnello M, Roux PP. Activation and Function of the MAPKs and Their Substrates, the 
MAPK-Activated Protein Kinases. Microbiology and Molecular Biology Reviews : MMBR. 
2011;75(1):50–83. 
22. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. 
Oncogene. 2007;26(22):3100–3112. 
23. Crystallization of MAP kinases. [accessed 2016 May 4]. 
http://www.sciencedirect.com/science/article/pii/S1046202306000703 
24. Turjanski A, Vaqué J, Gutkind J. MAP kinases and the control of nuclear events. Oncogene. 
2007;26(22):3240–3253. 
25. Bogoyevitch MA, Ngoei KRW, Zhao TT, Yeap YYC, Ng DCH. c-Jun N-terminal kinase 
(JNK) signaling: Recent advances and challenges. Biochimica et Biophysica Acta (BBA) - 
Proteins and Proteomics. 2010;1804(3):463–475. (Inhibitors of Protein Kinases). 
26. Weston CR, Davis RJ. The JNK signal transduction pathway. Current Opinion in Genetics 
& Development. 2002;12(1):14–21. 
27. Weston CR, Davis RJ. The JNK signal transduction pathway. Current Opinion in Cell 
Biology. 2007;19(2):142–149. (Cell regulation). 
28. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. 
Biochemical Journal. 2010;429(3):403–417. 
29. Kesavan K, Lobel-Rice K, Sun W, Lapadat R, Webb S, Johnson GL, Garrington TP. 
MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in 
fibroblasts. Journal of Cellular Physiology. 2004;199(1):140–148. 
30. Takeda A-N, Oberoi-Khanuja TK, Glatz G, Schulenburg K, Scholz R-P, Carpy A, Macek 
B, Remenyi A, Rajalingam K. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 
signaling module by XIAP and cIAP1. The EMBO Journal. 2014;33(16):1784–1801. 
31. Wang X, Finegan KG, Robinson AC, Knowles L, Khosravi-Far R, Hinchliffe KA, Boot-
Handford RP, Tournier C. Activation of extracellular signal-regulated protein kinase 5 
downregulates FasL upon osmotic stress. Cell Death & Differentiation. 2006;13(12):2099–
2108. 
References 
69 
 
32. Hayashi M, Lee J-D. Role of the BMK1/ERK5 signaling pathway: lessons from knockout 
mice. Journal of Molecular Medicine. 2004;82(12):800–808. 
33. Ranganathan A, Pearson GW, Chrestensen CA, Sturgill TW, Cobb MH. The MAP kinase 
ERK5 binds to and phosphorylates p90 RSK. Archives of Biochemistry and Biophysics. 
2006;449(1–2):8–16. 
34. Déléris P, Rousseau J, Coulombe P, Rodier G, Tanguay P-L, Meloche S. Activation loop 
phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, 
activation and cytoplasmic relocalization of MK5. Journal of Cellular Physiology. 
2008;217(3):778–788. 
35. Perander M, Keyse SM, Seternes O-M. New insights into the activation, interaction partners 
and possible functions of MK5/PRAK. Frontiers in Bioscience (Landmark Edition). 
2016;21:374–384. 
36. Perander M, Keyse SM, Seternes O-M. Does MK5 reconcile classical and atypical MAP 
kinases? Frontiers in Bioscience: A Journal and Virtual Library. 2008;13:4617–4624. 
37. Åberg E, Torgersen KM, Johansen B, Keyse SM, Perander M, Seternes O-M. Docking of 
PRAK/MK5 to the Atypical MAPKs ERK3 and ERK4 Defines a Novel MAPK Interaction 
Motif. The Journal of Biological Chemistry. 2009;284(29):19392–19401. 
38. Inoue H, Nojima H, Okayama H. High efficiency transformation of Escherichia coli with 
plasmids. Gene. 1990;96(1):23–8. 
39. Addgene: Plasmid Cloning by Restriction Enzyme Digest (with Protocols). [accessed 2015 
Dec 9]. https://www.addgene.org/plasmid-protocols/subcloning/ 
40. Struhl K. Subcloning of DNA Fragments. In: Current Protocols in Molecular Biology. John 
Wiley & Sons, Inc.; 1987. (13:3.16.1-3.16.2). 
41. Addgene: Protocol - How to Conduct a Restriction Digest. [accessed 2015 Dec 3]. 
https://www.addgene.org/plasmid-protocols/restriction-digest/ 
42. Restriction enzymes | Biotech Learning Hub. [accessed 2015 Dec 10]. 
http://biotechlearn.org.nz/themes/dna_lab/restriction_enzymes 
43. Assembly of Restriction Enzyme Digestions. 2011 [accessed 2015 Dec 10]. 
https://www.promega.com/~/media/files/resources/protocols/technical%20manuals/101/restri
ction%20enzymes%20protocol.pdf 
44. Moore DD, Dowhan D. Preparation and Analysis of DNA. In: Current Protocols in 
Molecular Biology. John Wiley & Sons, Inc.; 2002. (58:2.0.1-2.0.3). 
45. Voytas D. Agarose Gel Electrophoresis. In: Current Protocols in Molecular Biology. John 
Wiley & Sons, Inc.; 2000. (51:2.5A.1-2.5A.9). 
46. Addgene: Protocol - How to Run an Agarose Gel. [accessed 2015 Dec 12]. 
https://www.addgene.org/plasmid-protocols/gel-electrophoresis/ 
References 
70 
 
47. (EN) - QIAquick Gel Extraction Kit - QIAGEN. [accessed 2015 Dec 3]. 
https://www.qiagen.com/no/resources/resourcedetail?id=f4ba2d24-8218-452c-ad6f-
1b6f43194425&lang=en 
48. DNA Ligase. [accessed 2015 Dec 14]. 
http://www.biochem.umd.edu/biochem/kahn/molmachines/replication/DNA%20Ligase.htm 
49. Tabor S. DNA Ligases. In: Current Protocols in Molecular Biology. John Wiley & Sons, 
Inc.; 1987. (8:3.14.1-3.14.4). 
50. Avery OT, MacLeod CM, McCarty M. STUDIES ON THE CHEMICAL NATURE OF 
THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES. J 
Exp Med. 1944;79(2):137–158. 
51. Bacterial Transformation and Transfection. [accessed 2015 Dec 15]. 
http://dna1.genome.ou.edu/protocol_book/protocol_adxF.html 
52. Addgene: Protocol - How to do a Bacterial Transformation. [accessed 2015 Dec 3]. 
https://www.addgene.org/plasmid-protocols/bacterial-transformation/ 
53. QIAprep Spin Miniprep Kit - (EN) - QIAGEN. [accessed 2015 Sep 13]. 
https://www.qiagen.com/no/resources/resourcedetail?id=331740ca-077f-4ddd-9e5a-
2083f98eebd5&lang=en 
54. Li C, Wen A, Shen B, Jia L, Huang Y, Chang Y. FastCloning: a highly simplified, 
purification-free, sequence- and ligation-independent PCR cloning method. BMC 
Biotechnology. 2011;11:92. 
55. Bartlett JMS, Sterling D. PCR Protocols, second edition. Humana Press; 2003. 
56. PCR. [accessed 2016 Apr 6]. http://learn.genetics.utah.edu/content/labs/pcr/ 
57. Coen DMC. The Polymerase Chain Reaction. In: Current Protocols in Molecular Biology. 
John Wiley & Sons, Inc.; 2001. (56:15.0.1-15.0.3). 
58. Polymerase Chain Reaction (PCR). [accessed 2016 Apr 8]. 
http://www.ncbi.nlm.nih.gov/probe/docs/techpcr/ 
59. Gateway Recombination Cloning Technology. [accessed 2016 May 8]. 
https://www.thermofisher.com/no/en/home/life-science/cloning/gateway-cloning/gateway-
technology.html 
60. E. coli Protein Expression Strains | NEB. [accessed 2016 Apr 20]. 
https://www.neb.com/products/protein-expression-and-purification-technologies/e-coli/e-
coli/e-coli-protein-expression-strains 
61. Francis DM, Page R. Strategies to Optimize Protein Expression in E. coli. In: Current 
Protocols in Protein Science. John Wiley & Sons, Inc.; 2010. 
http://onlinelibrary.wiley.com/doi/10.1002/0471140864.ps0524s61/abstract 
62. BL21-CodonPlus Expression Competent Cells - Details & Specifications. [accessed 2016 
Apr 20]. http://www.genomics.agilent.com/article.jsp?pageId=484 
References 
71 
 
63. NanoDrop 1000 Spectrophotometer V3.7 User’s Manual. [accessed 2016 Apr 10]. 
http://www.nanodrop.com/library/nd-1000-v3.7-users-manual-8.5x11.pdf 
64. Gallagher SR. One-Dimensional SDS Gel Electrophoresis of Proteins. In: Current Protocols 
in Molecular Biology. John Wiley & Sons, Inc.; 1999. (47:10.2A.1-10.2A.34). 
65. The QIAexpressionist TM. [accessed 2016 Apr 21]. 
http://www.chem.uky.edu/courses/che554/6_affinitychro/qiaexpressionist.pdf 
66. Magdeldin S, Moser A. Affinity Chromatography:  Principles and Applications. [accessed 
2016 Apr 22]. http://cdn.intechopen.com/pdfs-wm/33046.pdf 
67. Glutathione Sepharose 4 Fast Flow. [accessed 2016 Apr 19]. 
https://www.gelifesciences.com/gehcls_images/GELS/Related%20Content/Files/1314716762
536/litdoc71501697AH_20110830182604.pdf 
68. Smith J. Purification of Proteins by Conventional Chromatography. In: Current Protocols 
in Molecular Biology. John Wiley & Sons, Inc.; 1998. (44:10.9.1-10.9.2). 
69. Hagel H. Gel-Filtration Chromatography. In: Current Protocols in Molecular Biology. John 
Wiley & Sons, Inc.; 1998. (44:10.9.3-10.9.32). 
70. Content Library - OpenStax CNX. [accessed 2016 Apr 21]. 
http://cnx.org/contents/uieDnVBC@20.16:28CLlnd_@2/Size-Exclusion-Chromatography- 
71. Dialysis Methods for Protein Research | Thermo Fisher Scientific. [accessed 2016 Apr 21]. 
https://www.thermofisher.com/no/en/home/life-science/protein-biology/protein-biology-
learning-center/protein-biology-resource-library/pierce-protein-methods/dialysis-methods-
protein-research.html 
72. Amicon® Ultra-15 Centrifugal Filter Devices. Merck Millipore Ltd. 
73. Transfection Protocols & Applications - QIAGEN. [accessed 2016 Apr 22]. 
https://www.qiagen.com/no/resources/molecular-biology-methods/transfection/ 
74. Cell Counting with a Hemocytometer: Easy as 1, 2, 3. Bitesize Bio. 2014 [accessed 2016 
Apr 22]. http://bitesizebio.com/13687/cell-counting-with-a-hemocytometer-easy-as-1-2-3/ 
75. Kingston RE. Introduction of DNA into Mammalian Cells. In: Current Protocols in 
Molecular Biology. John Wiley & Sons, Inc.; 2003. (64:9.0.1-9.0.5). 
76. Lipofectamine® LTX & PLUSTM Reagent. [accessed 2016 Apr 22]. 
https://tools.thermofisher.com/content/sfs/manuals/LipofectamineLTX_PLUS_Reag_protocol
.pdf 
77. Transfection. [accessed 2016 Apr 22]. https://no.promega.com/resources/product-guides-
and-selectors/protocols-and-applications-guide/transfection/ 
78. Western Blot: Technique, Theory, and Trouble Shooting. [accessed 2016 Apr 23]. 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456489/ 
References 
72 
 
79. Team:Brasil-USP/Notebook/protocols - 2015.igem.org. [accessed 2016 Apr 14]. 
http://2015.igem.org/Team:Brasil-USP/Notebook/protocols 
80. Pull-Down Assays. [accessed 2016 Apr 23]. 
https://www.thermofisher.com/no/en/home/life-science/protein-biology/protein-biology-
learning-center/protein-biology-resource-library/pierce-protein-methods/pull-down-
assays.html 
81. Schendel PF. Overview of Protein Expression in E. coli. In: Current Protocols in Molecular 
Biology. John Wiley & Sons, Inc.; 1998. (41:16.1.1-16.1.3). 
82. Tabor S. Expression Using the T7 RNA Polymerase/Promoter System. In: Current Protocols 
in Molecular Biology. John Wiley & Sons, Inc.; 1990. (11:16.2.1-16.2.11). 
83. Carlsen TJO, Bjerga GEK. TEV protease protocol - expression, purification and use. The 
Norwegian Structural Biology Centre, University of Tromsø; 2012. (Updated 25.04.2013). 
84. Aruffo A. Expression of Proteins in Mammalian Cells. In: Current Protocols in Molecular 
Biology. John Wiley & Sons, Inc.; 1998. (60:16.12.1-16.12.7). 
85. Kingston B, Brent R. Protein Expression. In: Current Protocols in Molecular Biology. John 
Wiley & Sons, Inc.; 2005. (69:16.0.1-16.0.4). 
86. Gray D. Overview of Protein Expression by Mammalian Cells. In: Current Protocols in 
Protein Science. John Wiley & Sons, Inc.; 2001. 
http://onlinelibrary.wiley.com/doi/10.1002/0471140864.ps0509s10/abstract 
87. Déléris P, Rousseau J, Coulombe P, Rodier G, Tanguay P-L, Meloche S. Activation loop 
phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, 
activation and cytoplasmic relocalization of MK5. Journal of Cellular Physiology. 
2008;217(3):778–788. 
Appendices 
A 
 
APPENDICES 
Appendix A: Map of pET-15b  
Novagen 
 
  
Appendices 
B 
 
Appendix B: Map of pCold II 
Takara 
 
  
Appendices 
C 
 
Appendix C: 1 Kb Plus DNA Ladder 
Thermo Fischer Scientific 
0.9% agarose gel stained with ethidium bromide 
 
  
Appendices 
D 
 
 
Appendix D: SeeBlue® Plus2 Pre-Stained Standard with MES 
Thermo Fisher Scientific 
 
  
Appendices 
E 
 
Appendix E: Gel-Filtration Chromatogram of MK5-His 
 
  
Appendices 
F 
 
Appendix F: MagicMark™ XP Western Protein Standard 
Thermo Fisher Scientific 
 
 
  
Appendices 
G 
 
Appendix G: Map of pDEST15 
 
 
  
Appendices 
H 
 
Appendix H: Map of pDEST17 
 
